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The Health Technology Assessment (HTA) programme, part of the National Institute for Health Research (NIHR), was set up in 1993. It produces high-quality research information on the 
effectiveness, costs and broader impact of health technologies for those who use, manage and provide care 
in the NHS. ‘Health technologies’ are broadly deined as all interventions used to promote health, prevent 
and treat disease, and improve rehabilitation and long-term care.
The research indings from the HTA programme directly inluence decision-making bodies such as the 
National Institute for Health and Clinical Excellence (NICE) and the National Screening Committee 
(NSC). HTA indings also help to improve the quality of clinical practice in the NHS indirectly in that they 
form a key component of the ‘National Knowledge Service’.
The HTA programme is needs led in that it ills gaps in the evidence needed by the NHS. There are three 
routes to the start of projects.
First is the commissioned route. Suggestions for research are actively sought from people working in the 
NHS, from the public and consumer groups and from professional bodies such as royal colleges and NHS 
trusts. These suggestions are carefully prioritised by panels of independent experts (including NHS service 
users). The HTA programme then commissions the research by competitive tender.
Second, the HTA programme provides grants for clinical trials for researchers who identify research 
questions. These are assessed for importance to patients and the NHS, and scientiic rigour.
Third, through its Technology Assessment Report (TAR) call-off contract, the HTA programme 
commissions bespoke reports, principally for NICE, but also for other policy-makers. TARs bring together 
evidence on the value of speciic technologies.
Some HTA research projects, including TARs, may take only months, others need several years. They 
can cost from as little as £40,000 to over £1 million, and may involve synthesising existing evidence, 
undertaking a trial, or other research collecting new data to answer a research problem.
The inal reports from HTA projects are peer reviewed by a number of independent expert referees before 
publication in the widely read journal series Health Technology Assessment.
Criteria for inclusion in the HTA journal series
Reports are published in the HTA journal series if (1) they have resulted from work for the HTA 
programme, and (2) they are of a suficiently high scientiic quality as assessed by the referees and 
editors.
Reviews in Health Technology Assessment are termed ‘systematic’ when the account of the search, appraisal 
and synthesis methods (to minimise biases and random errors) would, in theory, permit the replication 
of the review by others.
The research reported in this issue of the journal was commissioned by the National Coordinating Centre 
for Research Methodology (NCCRM), and was formally transferred to the HTA programme in April 2007 
under the newly established NIHR Methodology Panel. The HTA programme project number is 06/91/02. 
The contractual start date was in June 2004. The draft report began editorial review in March 2009 and 
was accepted for publication in May 2009. The commissioning brief was devised by the NCCRM who 
speciied the research question and study design. The authors have been wholly responsible for all data 
collection, analysis and interpretation, and for writing up their work. The HTA editors and publisher 
have tried to ensure the accuracy of the authors’ report and would like to thank the referees for their 
constructive comments on the draft document. However, they do not accept liability for damages or losses 
arising from material published in this report.
The views expressed in this publication are those of the authors and not necessarily those of the HTA 
programme or the Department of Health.
Editor-in-Chief: Professor Tom Walley CBE
Series Editors: Dr Martin Ashton-Key, Dr Aileen Clarke, Professor Chris Hyde,  
Dr Tom Marshall, Dr John Powell, Dr Rob Riemsma and Professor Ken Stein
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The purpose of the irst part of the study was 
twofold. First, to determine which of two methods 
of case note review provide the most useful and 
reliable information for reviewing quality and 
safety of care, and for what purpose. Second, 
to determine the level of agreement within and 
between groups of health-care professionals 
(doctors, nurses and other clinically trained staff, 
and non-clinical audit staff) when they use the two 
methods to review the same record.
The results were also expected to inluence the 
methods of data capture for the second part of 
the study, which explored the process–outcome 
relationship between holistic and criterion-based 
quality-of-care measures (process measures) and 
hospital-level outcome indicators, grouped by 
mortality level.
0HWKRGV
In the irst part of the study, retrospective multiple 
reviews of 684 case notes were undertaken using 
both holistic (implicit) and criterion-based 
(explicit) review methods. Quality-of-care measures 
included evidence-based review criteria and a 
quality-of-care rating scale. Textual commentary 
on the quality of care was provided as a component 
of holistic review. Data collection was conducted in 
nine randomly selected acute hospitals in England, 
by hospital staff trained in case note review. These 
local review teams comprised combinations of 
three staff types: doctors (n = 16), specialist nurses 
(n = 10) and clinically trained audit staff (n = 3) 
(n = 13 in total), and non-clinical audit staff (n = 9).
During the second part of the study, process 
(quality and safety) of care data were collected 
from the case notes of 1565 people with either 
chronic obstructive pulmonary disease (COPD) or 
heart failure in 20 randomly selected hospitals in 
England. Doctors collected criterion-based data 
from case notes and used implicit review methods 
to derive textual comments on the quality of care 
provided and score the care overall.
$QDO\VLVPHWKRGV
Intra-rater consistency, inter-rater reliability 
between pairs of staff using intraclass correlation 
coeficients (ICCs), completeness of criterion 
data capture, within- and between-staff group 
comparison, and between-review-method 
comparison. To explore the process–outcome 
relationship, a range of publicly available health-
care indicator data were used as proxy outcomes in 
a multilevel analysis.
5HVXOWV
A total of 1473 holistic reviews and 1389 criterion-
based reviews were undertaken in the irst part of 
the study.
When same staff-type reviewer pairs/groups 
reviewed the same record, holistic scale score inter-
rater reliability was moderate within each of the 
three staff groups (ICC 0.46–0.52), and inter-rater 
reliability for criterion-based scores was moderate 
to good (ICC 0.61–0.88). When different staff-type 
pairs/groups reviewed the same record, agreement 
between the reviewer pairs/groups was weak to 
moderate for overall care (ICC 0.24–0.43).
Comparison of holistic review score and criterion-
based score of case notes reviewed by doctors and 
by non-clinical audit staff showed a reasonable 
level of agreement between the two methods (p-
values for difference 0.406 and 0.223, respectively), 
although results from all three staff types showed 
no overall level of agreement (p-value for difference 
0.057).
Detailed qualitative analysis of the textual data 
provided by reviewers indicated that the three 
staff types tended to provide different forms of 
commentary on quality of care, although there was 
some overlap between non-clinical audit staff and 
the nursing group and between the nursing group 
and the doctors. Thus the non-clinical audit staff 
mainly reported facts from the case notes. Nurses 
and clinical audit staff provided commentaries that 
were mainly about process of care, together with 
([HFXWLYHVXPPDU\
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some implicit judgements about the quality of care 
provided. Information from the doctors tended 
to be more focused on technical aspects of care, 
making rather more explicit judgements on quality 
of care.
In the process–outcome study there generally were 
high criterion-based scores for all of the hospitals, 
while there was rather more inter-hospital variation 
between the holistic review overall scale scores. 
Rich textual commentary on the quality of care 
veriied the holistic scale scores. While there were 
trends towards hospitals that had lower mortality 
also having higher quality-of-care scores, none of 
these differences was statistically signiicant. There 
was only limited correlation between the outcome 
indicators and the criterion-based or holistic scale 
scores for either condition across the 20 hospitals.
&RQFOXVLRQV
Using a holistic approach to review case notes, 
groups of the same staff type can achieve 
reasonable repeatability within their professional 
groups when asked to rate quality of care on a 
scale. But there is little agreement between the 
three staff types when using holistic review methods 
to rate quality of care for the same clinical record, 
possibly because the different staff types are 
exploring different aspects of quality of care, as the 
qualitative analysis suggests.
All three staff groups have reasonable to high levels 
of consistency when using criterion-based review 
and, because there tend to be low levels of missing 
values in the data collected by all three staff types, 
there is little to choose between the staff groups in 
terms of reviewer effectiveness.
When the same clinical record was reviewed by the 
doctors, and by the non-clinical audit staff, using 
irst holistic and then criterion-based methods, 
there is no signiicant difference between the 
assessments of quality of care generated by the 
two methods. This suggests that although the two 
methods are exploring quality of care differently, 
they can allow similar levels of quality ratings to be 
made. When measuring quality of care from case 
notes, therefore, consideration needs to be given 
to three important factors: the method of review, 
the type of staff to undertake the review, and the 
methods of analysis available to the review team.
It is likely that review of quality of care can be 
enhanced by using a combination of both criterion-
based (explicit) methods and structured holistic 
(implicit) methods, which will identify both 
evidence-based elements of care and the nuances 
of care that are almost always a component of care 
in long-term conditions. Free textual commentary 
on the quality of care provided is a valuable asset 
in judging care, but it is complex to analyse and is 
likely to remain as a research tool in this ield of 
health-care evaluation.
Variation in quality of care can be identiied from a 
combination of holistic scale scores and textual data 
review to provide a rich means of understanding 
the outcome of care on an individual patient basis.
Although there are some correlations between 
quality-of-care scores and hospital-level outcome 
data, there is no clear relationship between the 
process of care and hospital-level outcomes for 
the two indicator conditions in this study. This 
probably relects the complexity of the process–
outcome relationship at the group level. Available 
hospital-level outcome indicator data are probably 
insuficiently sensitive to relect the quality of care 
recorded in patient case notes. Furthermore, high-
quality care may be given even when the patient’s 
outcome is poor, and vice versa. These indings 
may be pointing to process measures as being more 
useful than outcome measures when reviewing 
the care of people who have chronic disease or 
multiple conditions.
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The study had two main aims, which were agreed in response to a call for proposals from 
the National Coordinating Centre for Research 
Methodology (now part of the NIHR Health 
Technology Assessment programme). These aims 
were:
1. To compare the validity and reliability of two 
methods of case note review of quality and 
safety of care. That is, to explore which of two 
methods of case note review – holistic (implicit) 
review or criterion-based (explicit) review –  
is the most effective method of reviewing 
quality of care, and under what circumstances 
and by which type of staff. Methodological 
questions include a comparison of reliability of 
holistic (implicit) and criterion-based (explicit) 
methods.
2. To investigate whether there appears to be 
a link between the quality of medical care, 
as recorded in case notes, and the outcome 
of hospital care, for two chronic medical 
conditions. Methodological questions include 
an exploration of how implicit and explicit 
case note review might be used to explore the 
relationship between process of care and risk-
adjusted outcomes.
Since the aims are linked but address two different 
aspects of case note review – the methodology of 
case note review and process–outcome relationship 
– this report is presented in two main parts 
(Chapters 2 and 3), and the overall summary 
and future research agenda presented as a whole 
(Chapters 4 and 5). Figure 1 shows where the 
linkages lie between the two studies, particularly 
through the choice of review methods, type of 
reviewers and methods of selection of hospitals.
Additionally, there are two small studies that were 
also commissioned as part of the programme of 
work. One uses the review methods to explore their 
value in the context of structured record-keeping 
in stroke care. The second study explores the 
literature relating to the use of trigger tools when 
reviewing paper-based case notes for quality and 
safety. These studies are presented in Appendices 
13 and 14, respectively.
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Review of the quality of care as described in 
written case notes has become a standard means of 
assessing variation from quality standards and for 
identifying adverse incidents, either concerning 
individuals or groups of patients.
Quality of care is currently assessed from clinical 
records by collecting data using two principal 
approaches: holistic review (sometimes called 
implicit review) and criterion-based (explicit) 
review. Both of these approaches have recognised 
strengths and weaknesses, whether they are being 
used for performance monitoring and assessment 
or in a research setting.
Although attempts to systematise the review 
of quality of care began nearly a century ago 
with the work of Codman in 1912,1 much of the 
development of case note review methodology 
began in North America in the 1970s with the 
work of the Peer Review Organisations, which used 
implicit review methods (sometimes called ‘holistic 
methods’) to determine variations in the standards 
of care provided by hospitals.2 Subsequently, 
variants of these holistic (implicit) methods to 
review the quality of care of hospital patients were 
used as the basis for determining adverse event and 
medical error rates in three large epidemiological 
studies in New York state,3 Australia,4 and in 
Colorado and Utah.5 Holistic review was widely 
used, subsequently, in clinical audit in the UK.
Clinical staff in the UK are accustomed to looking 
through a set of patient records in order to form 
an opinion on the quality of care delivered. This 
holistic approach uses professional judgement 
and has the advantage that it requires no prior 
assumptions about the individual case, can be 
applied to any condition, can extend to examining 
any aspect of care, and, at least in experienced 
hands, may be relatively quick to perform. 
However, the standards against which quality 
is judged holistically are implicit, being to a 
considerable extent dependent on the reviewer’s 
personal knowledge and perspective, and thus 
are subjective. As a result the use of implicit 
professional judgements as the basis for reviewing 
quality and identifying variations from good 
practice has been increasingly criticised.
Research has identiied a range of assumptions 
about what is being measured by holistic (implicit) 
review, and problems have been identiied with 
the reliability and the validity of the approach. 
Weingart et al.6 conducted a retrospective record 
review of 1025 case notes to compare explicit and 
implicit review methods when examining quality 
of care. Their study found that implicit reviews 
by physicians tend to take a global approach, 
including an assessment of the severity of the case, 
but are less likely than nurses to take into account 
any process issues that may lead to reduced quality 
of hospital care. This inding was supported by the 
results of a study by Gibbs and colleagues,7 who 
compared quality of care for patients selected using 
higher- and lower-than-expected mortality rates. 
The authors highlighted the insensitivity of implicit 
methods when used for detecting hospital-level 
differences and reported that implicit chart reviews 
are not successful at discovering differences in 
quality of care.
Ashton et al.8 found that not only can implicit 
review be highly idiosyncratic and reviewer 
dependent, but also it can result in lower levels 
of inter-rater reliability than explicit methods 
at patient level. Moreover, reanalysis of data 
from the Utah and Colorado Medical Practice 
Study has contributed to concerns that holistic 
record review may have low reliability, with the 
inding that different implicit review strategies 
produced different estimates of the total number 
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of adverse events and negligent adverse events.9 
Despite attempts to reduce levels of subjectivity 
in holistic review (for example by such means 
as providing extensive training for physician 
reviewers), a number of other concerns remain 
about the value of review methods that are based 
principally on professional judgement. Inter-rater 
reliability between reviewers has been identiied 
as being particularly problematic, with Hofer 
and colleagues10 inding levels of between 0.25 
(low) and 0.45 (modest) in a study of a range of 
diseases and service settings. It may also be that 
the choice of methods of assessing reliability may 
have some effect on the results of studies, since the 
kappa statistic is inluenced by the prevalence of 
events.11,12 Additionally, the individual consistency 
of reviewers has been questioned,13 and the 
individual reviewer’s bias towards harshness or 
leniency has been considered as problematic in 
comparing results between reviewers.14 Fischoff ’s15 
initial work on hindsight bias has recently been 
reiterated as a confounding factor in implicit 
review.16 For these reasons, criterion-based review, 
using predeined criteria, has been proposed as 
a more reliable means of assessing quality from 
clinical records.17,18
Criterion-based (explicit) methods of review are 
an acknowledged alternative method to holistic 
review and have been widely used in the UK and 
in the USA. Standardised methods for developing 
explicit evidence-based review criteria were 
proposed by an Agency for Health Care Policy 
and Research working party in 199518 and were 
further developed by Hadorn and colleagues.19 
Criterion-based review allow comparison of care 
against explicit standards (such as those derived 
from national clinical guidelines). It requires the 
deinition of unambiguous questions to construct 
variables that can be retrieved from the case 
records and, although only predeined questions 
can be addressed, the variables have good 
reproducibility.
Derivations of these methods, using locally based 
standards of care as a template for identifying 
variations from care standards, were used in a large 
UK study of general practice during the 1980s.20 
Subsequently, a number of structured methods 
for developing review criteria for explicit quality 
review of case notes have been developed in the 
UK, including methods for developing criteria 
directly from evidence-based clinical guidelines.21 
These methods all seek to determine the rate 
of conformance with the criteria within a single 
patient’s care and are aggregated across a group 
of patients, recorded as a percentage. Patient 
preferences and clinical choices, based on the 
severity and the anticipated outcome of the case, 
are allowed for in estimating conformance and 
are not considered to be ‘violations’ of a standard 
of care. Criteria can thus be developed for any 
condition where there are externally agreed explicit 
standards of care.
This approach is becoming part of UK health 
policy. All clinical practice guidelines now being 
published by the National Institute for Health 
and Clinical Excellence (NICE) are now being 
accompanied by evidence-based review criteria to 
support review of clinical quality (see, for example, 
criteria published with the NICE guideline on the 
management of chronic heart failure22).
Clinical audit in UK hospitals has adopted 
these objective, criterion-based approaches,23–25 
using explicit standards that are not profession 
dependent and have shown, for example, 
substantial variations in organisation and clinical 
care between hospitals.23
Nevertheless, criterion-based review has been 
criticised as an insensitive method that may not 
identify unexpected factors that might inluence 
outcomes of care,26,27 so that implicit review may 
have still retain some advantages. In some North 
American studies mixed methods have been 
adopted,6,9 where nurses used criterion-based 
review to identify a subset of problematic cases for 
subsequent holistic review by doctors, although 
this two-stage approach carries a risk of hindsight 
bias, such that those cases identiied as problematic 
by nurses might be reviewed more harshly by 
the physicians.14,17 Rubenstein and colleagues28 
proposed a structured form of implicit review in 
which a series of clear questions were asked of the 
reviewers, as distinct from seeking speciic data 
items as in explicit review, and Pearson et al.29 used 
this method to review the quality of nursing care.
Thus the decision on methods is not necessarily 
settled by the adoption of the criterion-based 
approach, which may fail to identify the nuances of 
health-care variation. Mohammed et al.27 reviewed 
the quality of care of 50 patients with stroke from 
each of four hospitals reported as having the ‘best’ 
mortality outcomes for stroke in the West Midlands 
area of the UK, and four reported as having the 
‘worst’ mortality outcomes. After adjusting for 
case mix using W-scores, the researchers identiied 
a number of issues that affected outcome. 
Some inluences were predictable, such as the 
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organisation of care. Some were unexpected, such 
as the inluence on outcomes of ‘do not resuscitate’ 
orders. The authors suggested that these 
unexpected inluences would have been identiied 
only by expert reviewing using holistic methods.
Decisions on which of the two review methods 
to use, and under which circumstances, are also 
clouded by the results from studies that have used 
mixed methods. Thus Weingart and colleagues6 
have suggested that nurses and doctors may use 
different types of information on which to make 
judgements of care quality (and thus may come 
to different judgements about an individual case). 
On the other hand, Keeler et al.30 used explicit 
and implicit methods and sickness (risk)-adjusted 
outcomes to review quality in different types of 
hospitals. They reported similar quality-of-care 
ratings for the speciic hospitals when using the two 
methods. Any differences in quality were thought 
to be the result of differences in the characteristics 
of the hospitals rather than the result of using 
different methods of record review.
Overall, then, there is real lack of clarity about 
choice of method for case note review – which 
method, in whose hands and for what purpose. 
Building on the international evidence, this study 
was designed to explore these issues further.
6WXG\DLPDQGUHVHDUFK
TXHVWLRQV
The irst study aim agreed with the research 
commissioners was: to compare the validity and 
reliability of two methods of case note review of 
quality and safety of care.
Research questions were:
• Do holistic (implicit) and criterion-based 
(explicit) methods of case note review identify 
the same variations in quality within the same 
record?
• Do holistic (implicit) and criterion-based 
(explicit) methods of case note review identify 
the same variations in quality across groups of 
records for the same clinical condition?
• To what extent do holistic and criterion-based 
methods of case note review provide similar 
results when used by reviewers from similar 
professional groups?
• To what extent do holistic and criterion-based 
methods of case note review provide similar 
results when used by reviewers from different 
professional groups?
• Which method of case note review and which 
staff type would be most appropriate for phase 
two of the study (on the relationship between 
recorded process of care and outcomes of 
care)?
0HWKRGV
&KRLFHRIFRQGLWLRQVUHYLHZ
PHWKRGVVHWWLQJVDQGVWDII
The overall research approach was to investigate 
holistic and criterion-based case note review 
methods across hospitals, with a range of risk-
adjusted levels of 28-day mortality, using two 
chronic illnesses as tracer conditions. Quality of 
care was assessed using each of the two review 
methods by reviewers from three professional 
groups. Each case note was reviewed using both 
methods and by between one and four reviewers.
&KRLFHRIFOLQLFDOFRQGLWLRQIRUUHYLHZ
The initial research brief for this study encouraged 
research teams to consider using a limited range 
of tracer conditions, mainly concerned with the 
care for people with chronic conditions. Three 
conditions were initially proposed for the study – 
care for people with chronic obstructive pulmonary 
disease (COPD), heart failure and stroke. Following 
discussions with the research commissioners, COPD 
and heart failure were the two conditions chosen 
for the study.
Chronic obstructive airways disease
About 10% of admissions through hospital 
UK Emergency Medicine Departments are for 
people with COPD, which has a high mortality 
rate at 3 months after index admission. A NICE 
guideline with review criteria was produced at the 
commencement of the study.31 An extensive set 
of review criteria were available from the national 
Royal College of Physicians (RCP) COPD audit, 
including a limited number that were considered 
predictive of survival.
Chronic heart failure
People with heart failure often have repeated 
episodes of hospital readmission. To support our 
choice of heart failure as one of the two study 
conditions, we took into account the availability 
of an evidence-based guideline,23 together with a 
limited set of audit review criteria that had recently 
become available from NICE and was produced by 
the RCP Clinical Effectiveness and Evaluation Unit 
(RCP CEEu). The guideline and review criteria 
also provided a basis for developing, within the 
study, an externally referenced set of review criteria 
$VVHVVLQJTXDOLW\RIFDUHIURPKRVSLWDOFDVHQRWHV

for safety and quality assessment for heart failure 
management. There were no national audit data 
available.
Cases for review
There are relatively few admissions per hospital 
per year of new cases of heart failure or COPD 
and much of the diagnostic work-up is undertaken 
in the primary care or outpatient setting. We 
therefore chose to study cases of admission for 
an exacerbation of either of these two tracer 
conditions and excluded admissions for diagnostic 
work-up.
These working deinitions for data collection were:
• Exacerbation of COPD An exacerbation is a 
sustained worsening of the patient’s symptoms 
from their usual stable state, which is beyond 
normal day-to-day variations, and is acute 
in onset. Commonly reported symptoms are 
worsening breathlessness, cough, increased 
sputum production and change in sputum 
colour.31
• Exacerbation of heart failure An exacerbation 
of heart failure is a sustained worsening of 
the patient’s symptoms from their usual 
stable state, which is beyond normal day-
to-day variations, and is acute in onset. 
Commonly reported symptoms are worsening 
breathlessness, tiredness and swelling of the 
feet and/or ankles.23
&KRRVLQJWKHQXPEHURIFDVHQRWHVIRU
UHYLHZ
In choosing the number of case notes for review 
we were unable to use prior hypotheses to assist 
in determining how many case notes would be 
required for the reliability studies. We considered 
using van Belle’s method32 of calculating the 
number of events (e.g. identiied opportunities 
for error as being event = 20 times the number 
of parameters) from which to assist with this 
calculation, but subsequently found that it was 
practically impossible to model the range of 
opportunities for error presenting in these complex 
care pathways. In addition, it was decided that 
the study was more likely to ind variations in care 
rather than identiiable adverse events, and that in 
health care there could be very large opportunities 
for error. We therefore took a pragmatic decision 
to select approximately 50 case notes per condition 
per hospital. This number also itted with the 
custom and practice of the RCP CEEu, in which 
about 60 case notes per hospital form the basis for 
review in national clinical audits, and this number 
of case notes had previously provided suficient 
data for studies of inter-rater reliability.24
For this irst phase of the study we therefore sought 
to obtain sets of 50 case notes from consecutive 
admissions for each condition in each of eight 
hospitals. That is, 800 case notes in total.
6HOHFWLRQDQGUHFUXLWPHQWRIKRVSLWDOV
DQGVWDII
A four-stage process was used to recruit eight 
study hospitals in England. First, Hospital Episode 
Statistics33 on 28-day mortality data for COPD 
and heart failure were accessed through the East 
Midlands Public Health Observatory. Hospitals 
were excluded from the selection process if they 
reported less than 200 inpatient cases per year for 
either condition, effectively excluding smaller or 
specialist acute hospitals. There were 136 hospitals 
in the inal data set.
Second, 28-day mortality data for the two study 
conditions for each hospital was combined, using 
simple averaging, to create an average 28-day 
mortality ratio for each hospital. Third, these 
were then ranked from the lowest mortality to the 
highest, and the data was split into four quartiles, 
each of 34 hospitals. And inally, from this ranking, 
hospitals were randomly selected in each of the 
lowest- and the highest-mortality quartiles.
&RPELQDWLRQVRIUHYLHZPHWKRGVDQG
SURSRVHGQXPEHUVW\SHVRIVWDII
In our initial research proposal we sought to create 
review teams in each hospital, comprising two types 
of personnel: clinical staff (for example nurses and 
staff working in clinical audit departments) and 
doctors in senior stages of their specialist training 
[medical specialist registrars (SpRs)]. This choice 
of types of staff was made in order to test some of 
the assumptions in the literature6 that medically 
qualiied reviewers undertake holistic case note 
reviews differently from other personnel. Different 
combinations of reviewer type would review the 
same records to test inter-rater reliability within 
types of reviewer and between types of reviewer. 
Each case note would be reviewed twice by each 
reviewer: irst using holistic methods and then 
criterion-based methods. We chose this sequence 
to reduce the bias on the holistic review results 
that might occur from a reviewer having previously 
examined the case notes to undertake criterion 
review.
Subsequent to these initial decisions on numbers of 
case notes and staff, a more limited set of reviews 
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was agreed with the research commissioning panel, 
because the costs of undertaking a full set of two 
reviews of each of 50 case notes across the eight 
hospitals using four reviewers per condition proved 
too great for the available study budget. This 
second proposal still retained the ability to make 
comparisons between types of reviewer and review 
methods, albeit with a smaller number of reviewers 
in total. Table 1 indicates the type of reviewers 
and frequency of review that were proposed. The 
number next to the code for clinical audit/nursing 
staff (CA) and physicians (P) indicates the number 
of reviewers sought for each condition in each 
hospital. Each reviewer was expected to evaluate 50 
sets of case notes.
For each of the two conditions the framework 
in Table 1 was used to calculate the number of 
reviews and reviewers for both the holistic and the 
criterion-based review methods, so that the total 
proposed number of case note reviews for the eight 
hospitals was 3600, using 400 case notes overall for 
each of the two conditions (800 in all).
5HFUXLWPHQWRIKRVSLWDOVDQGVWDII
Recruitment of study participants was a complex 
and time-consuming process, as participation 
required the agreement the COPD and heart 
failure clinical teams at each hospital and was 
also dependent on the availability of hospital staff 
to review records for the study. A total of eight 
hospitals were required for participation in this irst 
part of the study. Because we expected dificulties 
in recruiting hospitals, mainly a lack of availability 
of staff within hospitals to review records, a total 
of 20 randomly selected hospitals (10 in the lower-
mortality quartile and 10 in the higher-mortality 
quartile) were contacted and invited to participate 
in the study when only eight were actually required 
to participate in this phase.
From the initial 20 hospitals contacted, the study 
recruited ive hospitals in each quartile, including 
one reserve hospital per mortality quartile in an 
attempt to ensure that a minimum number of 
eight hospitals were available for the analysis. One 
reserve hospital subsequently dropped out, leaving 
a total of nine hospitals in the study – four in the 
lower-mortality quartile and ive in the higher-
mortality quartile (Figure 2).
Hospitals were invited to participate through 
contact with one of the specialists in COPD and 
one in heart failure management. In each selected 
hospital, consultants specialising in each of the 
two conditions were approached jointly by the 
RCP CEEu and the University of Shefield, with 
a request that they act as sponsors for the study. 
Their role was to recruit review staff, within the 
hospital, who would undertake the data collection 
for the study. Recruitment of the selected hospitals 
was completed when two specialists in a hospital 
agreed to act as sponsor and there were enough 
staff to undertake the reviews (Figure 3).
The proposed number of reviewers required for 
each condition at each hospital varied from one 
to four (see Table 1), and this request sometimes 
proved dificult to meet in some hospitals. Among 
the reasons affecting the recruitment of reviewers 
included whether the hospital had a dedicated 
audit department and the change-over time of 
7$%/( 3URSRVHGQXPEHUVRIUHYLHZHUVDQGW\SHVRIVWDIIIRUHDFKUHYLHZPHWKRGHDFKVWDIIPHPEHUWRXQGHUWDNHUHYLHZV
8SSHUPRUWDOLW\KRVSLWDOV
7RWDO+RVSLWDO +RVSLWDO +RVSLWDO +RVSLWDO
&23' &$ &$ &$3 &$3
+HDUWIDLOXUH &$3 &$3 &$ &$
7RWDOUHYLHZVIURP
FDVHQRWHV
    
/RZHUPRUWDOLW\KRVSLWDOV
+RVSLWDO +RVSLWDO +RVSLWDO +RVSLWDO
&23' &$ &$ &$ &$
+HDUWIDLOXUH &$3 &$3 &$3 &$3
7RWDOUHYLHZVIURP
FDVHQRWHV
    
2YHUDOOWRWDORI
UHYLHZVIRUHDFK
UHYLHZPHWKRG

$VVHVVLQJTXDOLW\RIFDUHIURPKRVSLWDOFDVHQRWHV

),*85( 5HFUXLWPHQWWRWKHVWXG\+) KHDUWIDLOXUH
),*85( 'LVWULEXWLRQRIKLJKHUDQGORZHUVWXG\PRUWDOLW\KRVSLWDOVD%R[SORWRI&23'KHDUWIDLOXUHPRUWDOLW\VKRZLQJGLIIHUHQFHV
EHWZHHQKLJKHUDQGORZHUPRUWDOLW\JURXSVE%DUFKDUWVKRZLQJLQGLYLGXDOKRVSLWDOOHYHOPRUWDOLW\UDWHV
+RVSLWDOVZLWK
ORZPRUWDOLW\

$Y
HUD
JH

GD
\P
RU
WDO
LW\
DF
UR
VV
&2
3'
DQ
GK
HDU
WID
LOX
UH






+RVSLWDOVZLWK
KLJKPRUWDOLW\
+RVSLWDOVZLWK
ORZPRUWDOLW\
$
YHU
DJH

GD
\P
RU
WDO
LW\
DF
UR
VV
&2
3'
DQ
GK
HDU
WID
LOX
UH






+RVSLWDOVZLWK
KLJKPRUWDOLW\
D E
KRVSLWDOVLQYLWHGWRWDNHSDUWLQSKDVH
(DFKUHYLHZHUUHYLHZVPD[&23'RU
+)UHFRUGVXVLQJKROLVWLFUHYLHZPHWKRG
(DFKUHYLHZHUH[SRUWVKROLVWLFUHYLHZ
GDWDWRWKHVWXG\WHDPIRUDQDO\VLV
KRVSLWDOVGRQRWZLVKWRSDUWLFLSDWH
1RWHZKHUHWKHUHLVPRUHWKDQRQH
UHYLHZHUIRUDFRQGLWLRQDWWKHVDPH
VLWHDOOUHYLHZHGWKHVDPH
UHFRUGV
(DFKUHYLHZHUH[SRUWVFULWHULRQUHYLHZ
GDWDWRWKHVWXG\WHDPIRUDQDO\VLV
(DFKUHYLHZHUWKHQUHYLHZVWKHVDPH
PD[&23'RU+)UHFRUGVXVLQJ
FULWHULRQEDVHGUHYLHZPHWKRGXVLQJ
VDPHSDWLHQWUHFRUGVDVIRU
KROLVWLFUHYLHZ
)RXUKRVSLWDOVZLWKORZPRUWDOLW\UDWHV+(6GDWD
6LWH$
UHYLHZHUV
&23'
+)
6LWH%
UHYLHZHUV
&23'
+)
6LWH&
UHYLHZHUV
&23'
+)
6LWH'
UHYLHZHUV
&23'
+)
6LWH(
UHYLHZHUV
&23'
+)
6LWH)
UHYLHZHUV
&23'
+)
6LWH*
UHYLHZHUV
&23'
+)
6LWH+
UHYLHZHUV
&23'
+)
6LWH-
UHYLHZHUV
&23'
+)
)LYHKRVSLWDOVZLWKKLJKPRUWDOLW\UDWHV+(6GDWD
SpR training posts. At the end of the recruitment 
period, three types of hospital staff (reviewers) 
were engaged in the study – doctors in specialist 
training, other staff with a clinical background (of 
whom many were nurses specialising in the care of 
one of the two tracer conditions) and non-clinical 
audit staff. Across the nine participating hospitals, 
the reviewers comprised 16 doctors, 10 specialist 
nurses (together with one clinically trained audit 
person, one pharmacist and one physiotherapist) 
and nine non-clinical audit staff (i.e. 38 reviewers 
in total).
'DWDFDSWXUHPHWKRGV
+ROLVWLFUHYLHZ
The concept of structured implicit review28 has 
been found to be valuable in North American 
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implicit review studies as a means of reducing the 
variability previously found in inter-rater reliability 
studies.10,11 Structured implicit review attempts to 
place a framework on data collection by providing 
headings that can be used in the ‘holistic story’. 
However, US-based authors working for the RAND 
Corporation28 chose to use what might be termed 
a mid-point between criterion-based and textual 
holistic review, using structured questions that 
were not as speciic as review criteria, but which 
organised responses to the questions in such a way 
that might be considered to ask closed questions of 
the data. See, for example, Box 1.
In this study, the concept of structured holistic 
review was developed to provide reviewers 
undertaking holistic reviews with a limited 
structure, but one that was at the same time not 
so directive as the structured implicit review 
framework developed by the RAND teams. In 
doing so, this allowed for different levels of health-
care quality to be identiied – from excellent 
care, to care not provided, to the identiication of 
adverse incidents.
Data was captured under three phases of care and 
for care overall:
• care during the investigation/assessment phase
• care during the initial management phase
• care during the pre-discharge phase
• quality of care overall.
Using this structured holistic framework, reviewers 
were asked to provide two forms of assessment of 
quality and safety of care. First, reviewers provided 
a written assessment of the quality and safety of 
care of each patient, using information from the 
case notes (paper and/or electronic records) of 
the most recent episode of inpatient care for an 
exacerbation of the illness.
For the phases of care, reviewers were guided by 
two prompts:
• Please comment on the care received by the 
patient during this phase.
• From the records, was there anything in 
particular worth noting?
Second, reviewers were asked to rate the care 
received by the patient for each of three phases of 
care – admission/investigations, initial management 
and pre-discharge care. Each phase was rated on 
a six-point scale (1 = unsatisfactory, 6 = very best 
care), and a deinition was provided for each of the 
points on the scale:
1. Care fell short of current best practice in 
one or more signiicant areas resulting in the 
potential for, or actual, adverse impact on the 
patient.
2. Care fell short of current best practice in more 
than one signiicant area, but is not considered 
to have the potential for adverse impact on the 
patient.
3. Care fell short of current best practice in only 
one signiicant area, but is not considered to 
have the potential for adverse impact on the 
patient.
4. This was satisfactory care, falling short of 
current best practice in only more than two 
minor areas.
5. This was good care, which fell short of current 
best practice in only one or two minor areas.
6. This was excellent care and met current best 
practice.
7. The format of the questions is set out in Box 2.
Next, in assessing the quality of care overall, 
reviewers were asked to comment on the care 
received by the patient overall.
An overall quality-of-care rating was requested 
for each patient review on a 10-point scale 
(1 = unsatisfactory, 10 = very best care, using only 
the two anchor points on the scale) to provide for a 
global rating of care quality. This was given a wider, 
more ine grained scale so that reviewers could 
assimilate their perceptions of care for all of the 
phases of care to give an ‘in the round’ assessment 
(Box 3).
$VVHVVLQJWKHTXDOLW\RIUHFRUGLQJLQWKH
FDVHQRWHV
Evaluation of the quality of care through case 
note review is critically dependent on the quality 
of recording in the case notes, together with that 
$VVHVVLQJTXDOLW\RIFDUHIURPKRVSLWDOFDVHQRWHV
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in associated data sources, such as computerised 
pathology and radiology results. It might be 
hypothesised that a poor record could prevent a 
high-quality retrospective critical review of care. 
Alternatively, there might be a relationship between 
poor case notes and poor quality of care. Factors 
enhancing the use of the record for case note 
review include the extent to which information is 
recorded and placed in the case notes, the detail 
or otherwise of the entry and the legibility of the 
entry.
It was anticipated that most of the information 
relevant to the study would be recorded on paper-
based case notes but that systems would vary from 
hospital to hospital, for example in the extent to 
which the principal case notes provided a holistic 
record of care or whether medical notes and 
nursing notes might be held separately.
Reviewers were therefore asked to assess the quality 
of each record at the end of the holistic review, 
using a six-point rating scale (1 = inadequate, 
6 = excellent):
1. The patient record contains gaps in three or 
more signiicant areas.
2. The patient record contains gaps in two 
signiicant areas.
%2; ,QYHVWLJDWLRQVH[DPLQDWLRQ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3. The patient record contains gaps in one 
signiicant area.
4. The patient records are satisfactory and only 
contain gaps in three or more minor areas.
5. The patient records are good and only contains 
gaps in one or two minor areas.
6. The patient records are excellent.
Reviewers were asked to complete their assessment 
in the form shown in Box 4.
5HYLHZFULWHULDGHYHORSPHQWIRU&23'
DQGKHDUWIDLOXUH
Criterion-based review does not seek judgements of 
care – it requires the reviewer to only identify and 
record speciic items of care. The purpose of review 
criteria when used in clinical audit is to gather data 
on which to make a judgement about the quality of 
care provided by an institution. However, for the 
purpose of this study, although the quality of care 
provided by the hospital was useful information, 
the prime objective was to investigate the extent to 
which data collection of a case note review method 
was reliable and in which type of staff ’s hands it 
was most reliable.
This objective meant that the number of review 
criteria used for each of the two conditions could 
be limited to a smaller number rather than, for 
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example, the full set used by national clinical 
audit projects (for instance the RCP COPD audit 
comprised about 75 clinical criteria in total).34
The review criteria were developed using 
established methods for developing explicit 
evidence-based review criteria from clinical 
guidelines.19,20,22 That is, for each of the two 
conditions, the irst draft of the criteria were 
developed from the evidence base in the relevant 
national clinical guideline23,31 and subsequently 
validated using expert opinion.
COPD review criteria
Information to form the irst draft set of criteria 
came from the national clinical guideline for the 
management of COPD,31 the limited associated 
set of review criteria from the guideline and, third, 
from the national RCP clinical audit for COPD.34 
From the guideline recommendations and the 
available review criteria the project team identiied 
a subset of criteria that might be useful in the study.
Reinement of the set was undertaken in three 
stages. First, the criteria were reviewed to 
determine whether the required data were likely to 
be available from case note review. This excluded a 
number of review criteria used in the national RCP 
audit,34 which were concerned with organisational 
effectiveness. Thirty-eight criteria remained.
Second, a questionnaire was sent to a selected 
group of respiratory physicians to seek their views 
on the value of the criteria for measuring quality 
of care. Seventeen senior physicians and specialist 
nurses ranked the criteria as:
• essential
• desirable
• non-essential.
Eleven criteria were removed as a result of this 
process.
Third, the structure and wording of each criterion 
in the data set was reviewed to ensure that it was 
clear, logical and could be captured from case 
notes. At the end of this process there were 37 
criteria for COPD care (see Appendix 1).
Heart failure review criteria
A similar approach was taken to the production of 
heart failure review criteria. A draft set of criteria 
was developed from information in the national 
clinical guideline for the management of heart 
failure23 and from the limited associated set of 
criteria for the guideline. Discussion within the 
project team identiied a subset of criteria that 
might be of value in the study.
Reinement of the set was undertaken in three 
stages. First, the criteria were reviewed to 
determine whether the required data were likely to 
be available from case note review. There were 34 
criteria.
Second, a questionnaire was sent to a selected 
group of cardiovascular physicians and specialist 
cardiovascular nurses to seek their views on the 
value of the criteria for measuring quality of 
care. Ten replies were received. One criterion was 
removed as a result of this process.
Third, the structure and wording of each criterion 
in the data set was reviewed to ensure that it was 
clear, logical and could be captured from clinical 
records. At the end of this process there were 33 
criteria for heart failure care (see Appendix 2).
An example of the external review questionnaire 
used for COPD can be found at Appendix 3. A 
similar style of questionnaire was used for review of 
heart failure.
'HYHORSLQJGDWDFDSWXUHWRROV
In order to facilitate the work of the reviewers and 
data transfer to the study team, data capture was 
developed through an electronic format based on 
Microsoft ACCESS©. Holistic data capture forms were 
developed from the format outlined in Holistic 
review (above), using separate screens for key data, 
case history data, phases of care and overall care 
(see Appendix 4, Figure 33, for an example). The 
database was constructed so that information could 
$VVHVVLQJTXDOLW\RIFDUHIURPKRVSLWDOFDVHQRWHV
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be transferred to the study team either by e-mail 
or by CD, irst removing all identiiable data to 
preserve anonymity for patients and staff. The 
hospital staff retained access to the full data set to 
provide for local analysis and audit should they so 
wish. Criterion-based review data collection ields 
were created in the same way as those for holistic 
data.
Because there was considerable variety of local 
systems and versions of Microsoft ACCESS© in the 
study hospitals, copies of Microsoft ACCESS© were 
purchased and made available to the reviewers 
where required. Provision was also made for staff to 
collect data on a paper form where data-processing 
facilities were dificult to access. For these records, 
data entry was undertaken by the research team 
from anonymised paper records.
Data were collected from consecutive admissions 
over a period of 6 months before the review process 
started in each hospital, a time period which varied 
slightly, but was approximately between January 
and July 2005.
5HYLHZHUWUDLQLQJDQGFDVHQRWHVHOHFWLRQ
VXSSRUW
The study sought to provide all reviewers with 
standardised training in case note review, the 
emphasis here being to train in the data capture 
methods. Each reviewer was provided with copies of 
clinical guidelines for COPD and heart failure care 
as a means of ensuring that all reviewers had an 
explicit database of the standards of care expected 
for the two conditions.23,31 Other than providing 
the guidelines, in this part of the study there was 
no intention to try to inluence each reviewer’s own 
implicit standards for quality of care – that is, each 
reviewer would have their own, internal, standards 
for the care that they were reviewing.
During a day-long training session, reviewers were 
provided with an introduction to the two review 
methods (particularly as most reviewers were not 
familiar with the holistic method), together with 
review software training. Quality-of-care variation 
was discussed using four theoretical scenarios from 
stroke care that contained aspects of good and poor 
care (see Appendix 5). Stroke care was chosen for 
training to avoid biasing the reviewers in their view 
of quality of care for the two study conditions.
The challenges of inding information in paper-
based records and dealing with missing data were 
also considered along with a discussion about the 
means of obtaining case notes from the hospital 
records departments. Particular attention was 
paid to identiication of case notes of admissions 
for exacerbation of known COPD or heart failure 
(rather than new cases or admissions for a main 
condition that was not related to the study), and 
to selecting case notes from the most recent 
admission.
During the data collection period a telephone 
helpline was made available throughout ofice 
hours if reviewers had any queries or required 
advice about the data collection. The study team 
also contacted each reviewer regularly throughout 
the study period to track progress with the reviews, 
and liaised with relevant hospital medical record 
departments if reviewers had problems obtaining 
records.
$QDO\VLVPHWKRGV
2YHUDOODSSURDFK
The quantitative analysis was designed to 
investigate the extent of reliability between 
individual reviewers and groups of reviewers of 
the same, and different, professional backgrounds, 
using measures of internal (intra-rater) consistency, 
and between-reviewer (inter-rater) reliability for 
holistic quality-of-care scale scores and criterion-
based scores. Correlation and regression analyses 
were undertaken.
Detailed qualitative analysis of the textual data 
provided on the phases of care and the overall care 
was undertaken to explore the relationship between 
the holistic scale scores for each case and the 
narrative assessment. This analysis was also used 
to explore any differences between the results from 
the different professional groups undertaking the 
reviews.
+ROLVWLFVFDOHVFRUHDQDO\VLV
To assess intra-rater consistency (that is, whether 
reviewers were internally consistent in their ratings 
of care) for each individual review, the mean 
scale score rating was calculated across the three 
phases of care (admission/investigations, initial 
management and pre-discharge). The Pearson 
correlation coeficient was calculated between the 
mean rating of the three phases (each on a six-
point scale) and the overall rating (on a 10-point 
scale) within each review. The purpose of this 
analysis was to examine the consistency of the 
reviewer’s scoring across the phases of care and 
in the inal overall care to discover, for example, 
whether some reviewers might provide quite low 
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scores for one or more phases of care and then a 
rather higher score for overall care.
Intraclass correlation coeficients (ICCs) were 
used as the principal measure of agreement.35 
However, although the kappa statistic is susceptible 
to prevalence (in this case, of ‘opportunity for 
error’ rates per set of records),10,11 kappa scores 
were also computed as measures of agreement for 
overall scores (see Table 6b below), as this measure 
of agreement is more commonly used in the 
literature.
To assess inter-rater reliability between ratings of 
the same record by different reviewers, raw ratings 
were converted to ranks to adjust for variation in 
the range of scores used by different reviewers and 
ICCs were calculated on these ranks.
0HDVXULQJUHOLDELOLW\EHWZHHQUHYLHZHU
SDLUV
The ICC gives the correlation between any two 
measurements or ratings for the same subject 
or patient, using randomly chosen methods or 
reviewers. ICCs are based on continuous data, 
unlike kappa statistics, which require the data to be 
categorical. ICCs were used to assess the reliability 
between reviews of the same patient records carried 
out by pairs or groups of reviewers (e.g. two nurses 
or two doctors) at the same hospital and were 
calculated irst between the holistic quality-of-care 
ratings allocated by the two reviewers, and, second, 
between the criterion-based scores.
When undertaking the holistic (implicit) review, 
each reviewer rated the overall quality of care 
received by each patient against a 10-point scale. 
It is possible that different reviewers may have 
interpreted the rating scale differently (e.g. one 
reviewer may tend to give higher or lower ratings 
than another). Therefore, each reviewer’s ratings 
were converted to a rank. For example, if a 
reviewer reviewed 50 records then the ratings were 
ranked from 1 to 50. (In the event of tied ratings, 
the average rank was used.) The reliability between 
these ranked ratings for each pair of reviewers was 
then assessed using ICCs.
For the criterion-based review, care was assessed 
against a set of condition-speciic criteria for either 
COPD or heart failure care. ICCs were used to 
assess the inter-rater reliability between the overall 
number of criteria (as unranked criteria scores) 
noted by each reviewer as having been met.
Average reliabilities per staff type
To provide an overview of the average reliability for 
each staff type (e.g. doctors versus doctors, nurses 
versus nurses), a pooled or overall mean ICC was 
calculated across all the reviewer pairs in each staff 
group. Because some reviewer pairs had reviewed 
more records than others, each ICC was weighted 
when calculating the overall mean ICC, with the 
weight being proportional to the inverse of the 
variance of the ICC estimate.
Sites with more than two reviewers of 
different types
For sites where there were two reviewers of one staff 
type plus one of another type (e.g. two doctors and 
one nurse), we wished to avoid counting the same 
nurse twice in the comparison with the doctors. 
Therefore, the mean of the two doctors’ scores for 
each record was calculated (and the mean holistic 
scores converted to a rank). An ICC was calculated 
between the mean score from the two doctors and 
the score from the nurse. This approach was used 
whenever there were odd numbers of a reviewer 
type in this analysis. The ICC was then combined 
with the doctor–nurse ICCs from other sites to 
calculate an overall mean ICC for doctors versus 
nurses, weighting by inverse variance as described 
above. At site B there were three, rather than two, 
doctors reviewing the same records. Therefore, a 
single ICC was calculated among all three doctors’ 
scores at this site.
For the purpose of the analysis, care was rated on 
a three-point scale: (1) care fell short of current 
best practice (unsatisfactory); (2) satisfactory; and 
(3) good or excellent care. We considered whether 
it might be possible to reduce down the scale score 
data to a binary ‘poor’ or ‘good’ score to enable 
direct comparisons on a 2 = 2 table between the two 
review methods, but this approach would reduce 
the spread of judgements even further from the 
six- or 10-point scales and would not accommodate 
the range of judgements offered by the reviewers.
&ULWHULRQEDVHGUHYLHZ
Data were scored in two ways, irst to assess 
the completeness of the data and to assess the 
effectiveness of each reviewer type at completing 
the data collection form, and, second, to calculate a 
quality-of-care score for each review.
An ‘effectiveness of reviewer’ score for each record 
review comprised one point allocated for each data 
ield completed by the reviewer (irrespective of 
whether the criterion was recorded as being met or 
$VVHVVLQJTXDOLW\RIFDUHIURPKRVSLWDOFDVHQRWHV
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not being met), and one point subtracted for every 
data ield left blank by the reviewer. These scores 
were converted to a percentage.
Quality-of-care scores for each record comprised 
the percentage of the criteria identiied by the 
reviewer as having been met. ICCs were used to 
estimate inter-rater reliability for overall scores by 
pairs or triplets of staff reviewing the same records. 
Because some phases of care generated only a 
small number of criteria, ICCs were not computed 
for phases of care.
Intraclass correlation coeficient estimates from the 
different combinations of reviewers were pooled 
using a weighting that was inversely proportional to 
the variance of the estimate.36
&RPSDULVRQRIKROLVWLFVFDOHVFRUHVDQG
FULWHULRQEDVHGUHYLHZ
Inter-rater reliability results for each of the two 
review methods were compared. Additionally, an 
estimate of the within-staff-type consistency across 
the two review methods was calculated using p-
values for differences between the overall holistic 
quality-of-care ratings and the percentage of 
criteria recorded as being met.
&RPSDULVRQRITXDOLW\VFRUHVZLWK
KRVSLWDOVJURXSHGE\PRUWDOLW\OHYHO
In the original call for proposals for this study 
it was suggested that the quality-of-care scores 
might be risk-adjusted by severity of illness of 
each case. However, we agree with Daley and 
colleagues37 that risk adjustment remains a 
controversial and dificult subject. Pitches et al.38 
undertook a systematic review of 36 studies, which 
included 51 ‘process versus risk-adjusted mortality 
relationships’, exploring the extent to which 
variations in risk-adjusted mortality rates were 
associated with differences in quality of care. They 
found a positive correlation in only 51% of the 
relationships, with no correlation in 31% and an 
unexpected correlation in a further 18%, in what 
was a very heterogeneous set of studies.
A range of approaches to risk adjustment were 
considered in the initial phases of the study. 
Because of the complexity of data capture and the 
level of workload that could reasonably be asked 
of the reviewers, individual scoring of the risk for 
individual patients proved impossible. The chosen 
approach was therefore to compare aggregate 
quality-of-care results between the hospitals in the 
low- and high-mortality-rate groups.
$QDO\VLVRIKROLVWLFWH[WXDOGDWD
The comments made by the reviewers in their 
holistic reviews were in two free text areas. The 
irst asked them to comment on the care received 
during a particular phase of care or for care 
overall. The second asked if there was anything in 
particular worth noting from the records about the 
care (see Box 2, above).
Reviewers provided textual data when commenting 
on each of the four phases of care and the overall 
assessment of care. These data were analysed in two 
ways in order to address the question of whether, 
as suggested by Weingart and colleagues,6 different 
staff types were concerned with different elements 
of care when making their holistic assessments. 
Data from the past medical history heading was 
excluded from the analysis because there were few 
comments, and all were about the case notes rather 
than about care.
Content analysis
The primary approach was a content analysis 
drawing on grounded theory.39 The textual 
responses provided insights into the different 
ways that different individuals and different 
professional groups interpreted the task, as well as 
their interpretation of care provided. By analysing 
textual responses we were able to investigate 
similarities and differences between individuals 
about their interpretation of the same record, 
construct pictures of how professional groups 
interpreted the task and viewed care provision, and 
give an indication of the concepts that they used.
Categorising and coding types of 
comment made by reviewers
Following familiarisation with the textual responses, 
it became clear that different types of comments 
were given, relecting, in large part, different 
reviewer types. A categorisation was developed that 
identiied these different responses, irrespective of 
professional background. These categories could be 
thought of as hierarchical, to a degree, if set in the 
context of what might constitute an ideal review. 
Thus, at the lower end of the hierarchy were no 
comments, or limited comments, about the record 
rather than the care, ranging through different 
types of comment about care to the higher end of 
the hierarchy where the most discerning reviews 
picked up more complex issues. At the upper end 
there was a clear cluster of issues commented on 
overall, displaying a fairly sophisticated degree of 
reviewing. While the concepts emerged from the 
data, the labels attached to these categories were 
'2,KWD +HDOWK7HFKQRORJ\$VVHVVPHQW9RO1R
4XHHQ·V3ULQWHUDQG&RQWUROOHURI+062$OOULJKWVUHVHUYHG

developed by the research team. The concept terms 
were not used by the reviewers.
An initial set of codes was developed by ive 
analysts in group discussion. Output from three 
reviewers was then reviewed by two pairs of analysts 
(each separately), one pair examining COPD 
comments and the other examining heart  
failure comments. A ifth analyst examined all of 
the comments. Each pair of analysts discussed their 
experience of using the comments and compared 
their results. The results of the initial analysis and 
commentary on the utility of the coding framework 
were then discussed by the group, moderated by 
the ifth analyst and reinements were made to the 
coding frame.
These categories were then used to code all 
responses that made up the responses for each 
review. Since some of the responses were made 
up of a number of separate comments, the code 
given was the ‘highest-level’ category used in each 
of the comments. For each phase of care, and for 
care overall, up to four codes were allocated by the 
analyst. The analysis reported here refers to the 
highest level of code allocated by a reviewer for 
overall care for each set of case notes and refers 
only to the data collection item ‘Please comment 
on the care the patient received’. Thirteen coding 
categories were developed and these were also 
grouped into three broader categories (Box 5).
This categorisation was subsequently used to 
help identify the types of reviewing undertaken 
by different professional groups, which, in turn, 
assisted the decision on which group or groups of 
professionals best matched our requirements in the 
review process. Together with this categorisation of 
the type of reviewing being undertaken, the textual 
analysis was also used to identify speciic issues 
raised by reviewers and to see if they varied by 
professional group and by individual for the same 
record. Careful examination was undertaken of the 
particular words, phrases and style used in each 
comment, although not to the level of a discourse 
analysis. The constant comparisons allowed us to 
generate categories (themes) to identify different 
approaches to reviewing, different content of 
reviews, and contrasts between individuals and 
professional groups.
5HVRXUFHDQDO\VLV
In the initial proposal to the funding body we set 
out a proposal for a cost–beneit analysis of the two 
review methods. Because of resource constraints 
this did not form part of the inal agreement. 
However, we decided to undertake a limited 
resource analysis in case choices on reviewer type 
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might essentially be made on cost (where there 
were limited differences in review results between 
one or more types of reviewers or review methods).
The resource impact of each reviewer type was 
explored, based on self-reported data on the time 
taken to undertake each review and on annual 
staff cost data taken from Unit Costs of Health and 
Social Care 2005 (clinical and doctor reviewers) 
and mid-point administrative and clerical staff 
costs from Whitley Council pay rates (for non-
clinical audit reviewers).40 The mid-point on the 
scale was used as the cost for each staff type and 
only one cost for each staff type was used in the 
analysis.
Descriptive statistics for the time taken to 
undertake each review and the cost per review for 
each staff type were produced in SPSS. A mean time 
per review and a mean cost per review for each staff 
type was calculated. We also included the minimum 
and maximum range to look more closely at the 
spread of the data.
5HVHDUFKHWKLFVUHYLHZ
A research ethics review of the study was sought 
from the Trent Multi-centre Research Ethics 
Committee on 21 July 2004, prior to the start 
of data collection. Because, in both phases, data 
were to be collected by staff working in each 
hospital, and the data were anonymised before 
transmission to the research team, the Committee 
considered this to be equivalent to a national audit 
programme. The Trent Multi-centre Research 
Ethics Committee response was therefore that the 
study did not require an ethics opinion from the 
Committee.
5HVHDUFKJRYHUQDQFH
The potential need for research governance 
review existed in both parts of the study. However, 
because the data collection was being undertaken 
by hospital staff, the results were available to the 
individual hospital and the research team were 
not undertaking data collection on the hospital 
premises, the project was seen by research 
governance departments as akin to the national 
clinical audit programmes from which learning is 
derived as a result of the use of anonymous collated 
data. No study hospital required that a full research 
governance review should be undertaken, although 
initial discussions were held with a number of 
research governance teams and the offer to 
undertake the governance review process was made 
to all hospitals.
5HVXOWV
Across the nine hospitals, 38 reviewers undertook 
1473 holistic reviews and 1389 criterion-based 
reviews (a total of 684 clinical records were 
reviewed). The numbers of case notes reviewed by 
each individual ranged from nine to 50 (Table 2). 
Variation in the numbers of reviews achieved was 
related to job rotations, local workload pressures 
and dificulties in obtaining clinical records.
4XDOLW\RIFDVHQRWHUHFRUGLQJ
The mean quality of case notes rating for COPD 
and heart failure were 4.3 (SD 1.2) and 4.7 (SD 
0.9), respectively, on a scale of 1–6, indicating 
a reasonable overall quality of recording in the 
paper-based notes.
$QDO\VLVRIKROLVWLFUHYLHZVFDOH
VFRUHV
&RPSOHWLRQUDWHVIRUVFDOHVFRUHV
Data returned by reviewers was checked for 
completion rates. Tables 3 and 4 show completion 
rates in excess of 90% for all phases of care, except 
for the overall phase assessment completion rate 
for COPD reviews by non-clinical audit staff.
,QWUDUDWHUFRQVLVWHQF\LQKROLVWLFUHYLHZV
Across all three staff types there were statistically 
signiicant correlations (r > 0.71, p < 0.001) between 
the mean scale score ratings that reviewers assigned 
to the individual phases of care and their rating of 
the overall quality of care, indicating a fair to good 
level of intra-rater consistency in rating the quality 
of care using holistic review scale scores (Table 5). 
Reviewers appeared to be relatively consistent in 
the way that they scored quality of care for the 
phases of care in a case and then gave an overall 
assessment score for the episode of care.
,QWHUUDWHUUHOLDELOLW\IRUKROLVWLFUHYLHZ
Holistic review reliability between scale score 
ratings of the same record by pairs of reviewers was 
fair within all three staff types, although it varied 
from one reviewer pair to another and for some 
pairs was very poor (Table 6a). The overall weighted 
mean ICC was fair across all three types of 
reviewers, with no signiicant differences between 
staff types. Table 6b displays the same analysis using 
kappa statistics. The same trend occurs as in Table 
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6a, that is, the doctor reviewers have a higher level 
of agreement than the other staff types, although 
the results for the nurse/clinical group and the non-
clinical audit staff are somewhat lower than for the 
ICC analysis. This is likely to be due to differences 
in the two methods of analysis.
&RPSDULVRQVEHWZHHQSURIHVVLRQDO
JURXSV
Where reviewers from different staff types used 
holistic scale score methods to review the same 
record, inter-rater reliability was assessed within 
and between staff groups for all phases of care and 
overall care (Table 7). For the phase of care indings 
within staff groups there was generally modest to 
fair agreement within pairs, particularly among the 
doctors, although even in this group the range was 
large (see, for example, the initial management 
results), and, as we have stated in the paragraph 
above (relating to Table 6a), the level of agreement 
varied from one reviewer pair to another and for 
some pairs was very poor. However, where staff 
from different groups reviewed the same record, 
agreement between the different professional 
groups on their assessment of the quality of care 
was poor to non-existent.
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The overall ‘quality-of-care’ score for both holistic 
and criterion-based methods used across the 684 
patient records was similarly rated by the three 
staff types (between 70% and 79%, where 100% is 
very best care). Analysis of variance between the 
holistic overall scale ratings of the three staff types 
show that the nurse/other clinical group scores 
were signiicantly lower than the doctor (p < 0.001) 
and non-clinical audit groups (p < 0.001). The 
comparison of the last two groups showed no 
signiicant differences (p = 0.352).
$QDO\VLVRIUHYLHZFULWHULRQ
EDVHGVFRUHV
&ULWHULRQEDVHGUHYLHZHUHIIHFWLYHQHVV
Effectiveness scores relate to the ability of the 
reviewer to ind and access the data in the case 
record. For each criterion one point was allocated 
for each data ield completed by the reviewer 
(irrespective of whether the criterion was recorded 
as being met or recorded as not being met) and one 
point subtracted for every data ield left blank by 
the reviewer. Effectiveness in capturing criterion-
based data was high and similar across all three 
staff types (Table 8), with mean scores all being 
around 95% (that is, an average of approximately 
1.5 data items missing for each review).
,QWHUUDWHUUHOLDELOLW\IRUFULWHULRQEDVHG
UHYLHZ
Inter-rater reliability between criterion-based 
scores (that is, the percentage of criteria recorded 
as being met) for the same record by different 
reviewers ranged from moderate to good within 
all staff types, although with the doctors showing a 
signiicantly higher level of reliability (Table 9).
&RPSDULVRQRIKROLVWLFDQG
FULWHULRQEDVHGPHWKRGV
Table 10 shows the results of a comparison between 
holistic review and criterion-based review methods, 
using ‘quality-of-care’ scores. Reviewers rated the 
overall quality of care on a 10-point scale from 
1 (unsatisfactory) to 10 (very best care). This was 
converted to a percentage for comparison with 
criterion-based review data. Criterion-based 
quality-of-care scores are shown as percentages 
out of 32 criteria (where patient is a current or 
ex-smoker) or out of 31 criteria (where patient is a 
non-smoker).
Mean overall quality-of-care scores were similar for 
both holistic and criterion-based methods, and also 
for all three staff types (scores of between 70% and 
79%, where 100% is excellent care).
Paired individual data was used for the comparison: 
that is, the score for each criterion review of a case 
note minus the overall score for the holistic review 
of the case note.
There were 1109 paired sets of case note reviews 
in total (some reviewers only undertook one type 
of review on some case notes), so the paired review 
numbers are smaller than the possible total of 
1384 reviews. For the purposes of the analysis 
there are 1109 differences (criterion review score 
minus overall holistic review score). The conidence 
intervals (CIs) and p-values are adjusted for 
clustering by reviewer (in this case, 38 reviewers).
Estimation of the level of quality-of-care score 
agreement between the two methods for an 
individual record, using p-value for difference, 
shows that there was no signiicant difference 
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between the holistic and criterion-based 
assessments when used by the doctors (p-value for 
difference 0.406) and by the non-clinical audit staff 
(p-value for difference 0.223).
However, there was a difference (that is lack 
of agreement) between the two scores rated by 
the nurse/other clinical group of reviewers. It is 
possible that this was because of the differences 
between criterion-based methods and holistic 
methods of review. The review criteria tended to 
be clinical measurement based, certainly in the 
admission and initial management phases, whereas 
the qualitative data from holistic reviews (see 
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below) suggest that the nursing-trained reviewers 
were quite strongly inluenced by the quality and 
effectiveness of care pathways. Holistic review 
results may therefore be demonstrating a view that 
is more nursing focused than do the selected review 
criteria.
Bland–Altman plots of the difference in score 
between the review methods, against the average 
of the two scores, can also be used to examine the 
size of the differences and also their distribution 
around zero. The plot also allows for a visual check 
to determine whether the differences are (or are 
not) related to the size of the measurement.
For the purpose of this study, the average reviewer 
score across both methods acts as the best estimate 
of the true value. The mean difference, in review 
method scores, is an estimate of the average bias 
of one method relative to another. The standard 
deviation (SD) of the differences, or the 95% 
limits of agreement, can be used to see how well 
methods are likely to agree for an individual. 
For a systematic distribution we expect the range 
(mean ± 2 SD
DIFFERENCE
) to include about 95% of the 
observations. This range of values deines the 95% 
limits of agreement.
Figures 4–6 show that the reviewers tended to rate 
the majority of records with a mean combined 
holistic and criterion score of between 40 and 100, 
with very few records having lower scores relecting 
poorer care. There is some evidence of a systematic 
pattern, in all three plots, which suggests that at 
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lower average scores (up to 60) the holistic-based 
score tends to be less than the criterion-based 
score for the same reviewer/patient (i.e. negative 
differences). At higher average scores, above 60, 
then there is evidence of the opposite pattern, 
i.e. positive differences, which implies that the 
holistic-based scores are larger than the criterion-
based review scores for the same patient. These 
patterns, at both the higher- and lower-level scores, 
may be relecting the methodological differences 
of measuring quality of care. While the criterion-
based scores are rigid – the item is either present 
or absent – holistic scoring allows the reviewer to 
make a judgement, which might be ‘harsher’ than 
criterion-based scoring at lower-quality levels and 
more ‘favourable’ at higher-quality levels, as many 
more factors may be taken into account in the 
judgement in holistic reviewing. Evidence from the 
following section on the analysis of textual data 
may also support this hypothesis.
Both Table 10 and Figures 4–6 suggest that there was 
more variation in the holistic review results than in 
the criterion-based review. The reason for this may 
be due to the differing nature of the two review 
methods, as criterion-based review is by its nature 
very structured.
7KHPDWLFDQDO\VLVRIKROLVWLF
WH[WXDOGDWD
Textual comments on the quality of care were 
sought from reviewers as part of the holistic review 
process and a textual analysis was undertaken 
where any type of response was given to either of 
the following questions:
• Please comment on the care received by the 
patient during this phase (the irst box of the 
data collection form).
• From the records, was there anything in 
particular worth noting? (The second box of 
the data collection form.)
There was variation in the type and amount of 
comments given by reviewers. Some reviewers gave 
no response, others gave one or two words, while a 
list type response was given by some and extensive 
narratives were provided by other reviewers. The 
data are presented by staff type, followed by an 
overall summary analysis.
1RQFOLQLFDODXGLWVWDII
Several non-clinical audit staff reviewers made no 
comment in the irst box in most instances. In a 
few instances, those who made no comment did, 
however, offer a comment in the more general 
comments box (the second box). Among this 
reviewer group, the comments in the second box 
were sometimes about documentation rather than 
about the care delivered.
A relatively common approach by non-clinical audit 
staff was to present a list, of things that had been 
done or requested, or, in some instances, things 
that had not been done. In some instances the lists 
$VVHVVLQJTXDOLW\RIFDUHIURPKRVSLWDOFDVHQRWHV

),*85( 3ORWRIGLIIHUHQFHLQKROLVWLFFRPSDUHGZLWKFULWHULRQTXDOLW\RIFDUHVFRUHYHUVXVDYHUDJHVFRUH²VWDIIW\SHFOLQLFDO
²
²
²
²




   
$YHUDJHKROLVWLFDQGFULWHULRQVFRUH
'L
IIH
UHQ
FH
KR
OLVW
LF²
FUL
WHU
LRQ
LQ
VF
RU
HV
    

8SSHUOLPLWRIDJUHHPHQW
0HDQGLIIHUHQFH
/RZHUOLPLWRIDJUHHPHQW
),*85( 3ORWRIGLIIHUHQFHLQKROLVWLFFRPSDUHGZLWKFULWHULRQTXDOLW\RIFDUHVFRUHYHUVXVDYHUDJHVFRUH²VWDIIW\SHQRQFOLQLFDODXGLW
²
²
²
²




   
$YHUDJHKROLVWLFDQGFULWHULRQVFRUH
'L
IIH
UHQ
FH
KR
OLVW
LF²
FUL
WHU
LRQ
LQ
VF
RU
HV
    

8SSHUOLPLWRIDJUHHPHQW
0HDQGLIIHUHQFH
/RZHUOLPLWRIDJUHHPHQW
),*85( 3ORWRIGLIIHUHQFHLQKROLVWLFFRPSDUHGZLWKFULWHULRQTXDOLW\RIFDUHVFRUHYHUVXVDYHUDJHVFRUH²VWDIIW\SHGRFWRU
²
²
²
²




   
$YHUDJHKROLVWLFDQGFULWHULRQVFRUH
'L
IIH
UHQ
FH
KR
OLVW
LF²
FUL
WHU
LRQ
LQ
VF
RU
HV
    

8SSHUOLPLWRIDJUHHPHQW
0HDQGLIIHUHQFH
/RZHUOLPLWRIDJUHHPHQW
'2,KWD +HDOWK7HFKQRORJ\$VVHVVPHQW9RO1R
4XHHQ·V3ULQWHUDQG&RQWUROOHURI+062$OOULJKWVUHVHUYHG

were quite exhaustive; however, it was not possible 
to say whether the reviewer had included them 
because they had decided they were relevant to 
judgements about the care the patient received or 
simply because they looked important. It is dificult 
therefore to reach irm conclusions about how 
much selection had been exercised.
This attempt to reach conclusions was made 
more dificult by the fact that in some instances 
the comments were clearly lifted verbatim from 
the notes or, in other instances, a paraphrase 
was given, which might, perhaps, include some 
interpretation of what had taken place. A list of 
items by itself without any information about why 
they are important or how they related to other 
aspects of their care means that there is not a 
suficient narrative to allow a picture to be formed 
of what the reviewer thinks about the issue, let 
alone what their view is of the quality of care was 
delivered.
Another approach that was observed in the 
comments from this group was the attention to 
very speciic issues, such as timing of medication 
issues, lack of follow-up in terms of test results, 
details of transfers, information given to patient 
and family, timing of interventions/other aspects 
of care, including delay length if it occurred. This 
was sometimes the main approach taken. In other 
reviews it was combined with the list approach. Two 
reviewers did, however, pick up issues of adverse 
incidents or queried the care delivered in a couple 
of instances, but this was very much the exception 
rather than the rule.
On the whole, among this staff group, there was 
relatively little judgement directly expressed by the 
non-clinical reviewers about the care perceived. 
There was a limited amount of explicit and implied 
judgement, but from only relatively few of the 
reviewers. It was unclear in some instances how 
much selection had been made about what to 
include in the comments provided.
1XUVLQJDQGRWKHUFOLQLFDOVWDII
As with all staff groups, there was variation in 
the types of review comments made by nurses, 
although many reviewers in this group included 
an element of listing of what had, and had not, 
been done. In some instances there was only a 
list of actions and omissions. However, for most 
cases there was also other information and in 
many instances implied or explicit judgement for 
care in general or for speciic aspects of care. For 
example, many reviews gave information about 
what was done and commented on whether this was 
appropriate.
As with the non-clinical audit reviewers, some of 
the nurse reviewers mentioned documentation, 
but it was quite clear that they more often 
were concerned with care issues rather than 
documentation. Even the concentration of some 
nurse reviewers on care plans (which might be 
expected given the importance of this in nursing 
care) appeared to be more concerned with the 
content of the plan, rather than whether it was 
legible, which again tends to suggest a focus on 
care rather than documentation. In terms of 
comments about the plan, in most instances there 
was a judgement about the quality of the plan. 
Most of the comments about the plan were explicit 
judgements about it, and, in many instances, 
the views about the plan were the most explicit 
comments in terms of judgements made. In aspects 
of care other than the plan, the judgements were 
more often implied.
In terms of the areas of care that comments were 
made on, as might be expected many were about 
areas that might be considered the responsibility 
of nursing staff. For example, comments on review 
including observations, timing of medication 
administration, involvement of other nursing staff 
(such as specialist nurses), discharge planning, 
social circumstances, patient education and 
nutrition. However, a couple of nurse reviewers 
took a wider view and made comments on 
appropriateness of medication, investigations and 
teams involved in care. In some instances they 
also queried care provided. Several reviewers also 
picked up issues of concern, including potential 
and actual adverse events.
Overall, the nurse reviewers commented much 
more on the care delivered rather than the 
documentation, in contrast with the non-clinical 
audit reviewers. They also utilised the list approach, 
and, in some instances, it was combined with either 
implicit or explicit views about care delivered. 
While many focused on areas more traditionally 
thought of as nursing realms, one or two did give 
views (implicit, and, in one case, usually explicit) 
about medical as well as nursing care. It was easier 
to get an overall impression of the care delivered, 
what was delivered and views about the quality of 
care than with the non-clinical audit reviewers. 
However, the pictures were still patchy in most 
instances, and relied in many instances on the 
reader going with the implications, rather than 
being given an explicit view.
$VVHVVLQJTXDOLW\RIFDUHIURPKRVSLWDOFDVHQRWHV

'RFWRUV
As with the other two staff groups, there was 
considerable variation in the reviewing style and 
comments given by different medical staff who 
undertook reviews. The variation in comments 
provided ranged from no opinion or very brief 
opinions of care delivered to several lines that 
allowed a reasonable picture of the episode of care 
to be gleaned.
As with other staff groups, some element of listing 
what was done was evident in the comments from 
the medical staff. However, where this was done, 
the items listed were usually much fewer in number. 
Several reviewers gave limited comments but 
explicit judgements in almost all cases, so that their 
comments, as well as listing items, also contain 
some explicit judgements. If aspects of care had 
been omitted or delayed or the implication was 
that care could have been better, medical reviewers 
often gave further details that almost justiied their 
implied criticism.
One of the most striking differences between this 
staff group and the other two groups was that 
almost all of the medical reviewers who gave fuller 
answers routinely gave explicit opinions, views 
or judgements about the care delivered. Medical 
reviewers picked up issues where the care given 
was queried and alternatives were suggested, and, 
in some instances, adverse incidents or practice 
said to be unsafe were picked up. These were 
more frequent in reviews by medical staff than in 
nursing/clinical groups and non-clinical staff. It was 
noted, however, that in instances where care was 
perhaps not as good as it should be, the reviewers 
were sometimes less willing to give an explicit 
judgement, certainly not without adding additional 
comments (and much more so than when care was 
deemed satisfactory). In instances where poor care 
was commented on, the comment often included a 
statement about it not being clear or mentioned if 
certain actions/treatments were done. This may, or 
may not, be a relection of professional reluctance 
to criticise.
Overall, the medical reviewers gave explicit views 
about the care provided, often supplemented with 
comments that allowed a better picture of the 
episode of care to be gleaned. Their focus was on 
medical care rather than on nursing or patient-
centred issues, which might be expected, and it 
might be considered that the comments were on 
the domains/items that could have a greater impact 
on patient outcomes.
$OOUHYLHZHUV
There was variation in the type and amounts of 
comments given by reviewers. Some reviewers 
gave no response, others gave one or two words, 
while a list type response was given by some and 
extensive narratives were given by other reviewers. 
This variation might relect different levels of 
understanding of care received, willingness to offer 
views about the care received, or both.
On the whole, it was most dificult to get a view 
of care from the non-clinical audit staff. From the 
nursing/clinical group, more information about 
care was given, and generally more judgements 
were given, although they were often implicit and 
in the area of nursing care rather than care overall. 
The medical reviewers, while they tended to focus 
on medical aspects of care, usually gave an explicit 
view about the care given and picked up issues that 
were likely to have an impact on patient outcomes.
Except for the information about explanation 
and justiication of actions, proposed alternatives 
and views about likely impact (which was almost 
exclusively provided by the medical reviewers), the 
additional detail from lists provided by the other 
types of reviewers did little to help build a picture 
of the episode of care. In each group there was 
a variation in reviewing quality. The best in each 
group picked up issues of adverse incidents, unsafe 
care and gave a good account of the care episode, 
including their judgement about how good it was. 
In general the reviews provided by doctor reviewers 
gave a better representation of the care provided 
than did those of the nursing/clinical group which, 
in turn, was a better representation than that of the 
reviews from the non-clinical audit staff.
$QDO\VLVRIWKHW\SHDQGOHYHORI
FRPPHQWXVHGE\VWDIIJURXSV
Comments in all of the responses for overall care 
were coded using the framework provided in  
Box 5 (above). The codes were then grouped into 
three main bands to provide an overall assessment 
of the similarity of types and levels of coding 
between the three professional groups. These 
groupings were:
• codes 1–5: little or no comment about care and 
little or no judgement
• codes 6–8: limited comment about care and 
implied judgement
• codes 9–13: explicit judgement of care or 
more sophisticated comments about care with 
explicit judgements and views.
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The data are presented in tabular form in Table 
11 (COPD) and Table 12 (heart failure) and the 
analysis takes a null hypothesis. That is, there is 
no association between the level of coding given 
and staff type (i.e. the rows and columns are 
independent).
For the COPD reviews, across all of the phases of 
care and overall care, for both conditions, there 
were statistically signiicant differences between the 
types of comments made by the three types of staff, 
with the medical staff using the highest-level codes 
across all phases of care and overall care (Table 11). 
There is therefore some evidence to suggest that 
doctors are more likely to use explicit codes than 
the other staff groups.
For heart failure reviews, while there are still 
statistically signiicant differences between the three 
groups, the differences between the groups are less 
strong, with similarities the doctors and nurses for 
phases of care and little difference between the 
groups for overall care (Table 12).
The high percentage of high-level codes in the 
overall section for non-clinical audit staff may be 
due to the fact that there were only three non-
clinical audit reviewers for heart failure, and 
49 out of 70 of these reviews were done by one 
reviewer. Unusually for non-clinical audit reviewers, 
this reviewer, in the overall phase, usually put a 
comment such as ‘good all round care’ or ‘good 
nursing and medical care,’ hence it has been coded 
9 – explicit judgement. However, this judgement 
by the reviewer was not relected in the individual 
phases of care. It also appears that the nurses gave 
more high-level comments for heart failure than 
those for COPD, perhaps because there were a 
greater proportion of specialist nurses in the heart 
failure group.
Figures 7 and 8 provide a graphical representation 
of the data.
5HVRXUFHLPSOLFDWLRQV
Tables 13 and 14 summarise the data on resource 
use on holistic review and criterion-based review, 
respectively. For COPD holistic review (Table 13), 
doctors and nurses both took a similar amount 
of time to review each record (approximately 18 
minutes per review). However, the non-clinical 
audit staff took much longer to review each COPD 
record using holistic methods, with a mean review 
time of 34 minutes. The mean total cost per review 
data indicates that nurses had the lowest cost 
per COPD holistic review at £6.73, non-clinical 
staff had a cost per review of £8.53, and doctors 
incurred the highest cost per review at £10.16, 
despite taking the least time to undertake the 
reviews. Doctors incur higher costs per review than 
the other staff types because of the higher overall 
staff costs compared with the other staff groups in 
the study.
There was less variation between the different staff 
groups for the time taken to review heart failure 
records holistically (mean range 24.06–29.48 
minutes). Doctors were again found to be the most 
expensive staff group, with non-clinical audit staff 
incurring the least cost per review.
Cost per review for heart failure holistic reviews 
were slightly lower for each staff group than for the 
COPD holistic reviews.
For the COPD criterion-based reviews (Table 14) the 
non-clinical staff took the most time to complete 
each review. However, as with the holistic review 
data, the doctors incurred the highest cost per 
review. This pattern is repeated in the heart failure 
criterion data.
4XDOLW\RIFDUH²KRVSLWDO
PRUWDOLW\JURXSUHODWLRQVKLS
Of the nine study hospitals, ive were grouped 
together in the lower-mortality group and four 
were in the higher-mortality group, based on 
a calculation from Hospital Episode Statistics 
data (Figure 2, above). This analysis explores the 
relationship between these two groups of hospitals, 
which are ranked and grouped by mortality rates, 
and the quality-of-care data expressed as the group 
mean holistic scale scores for overall care and the 
group mean percentage criterion score. Data are 
presented in tabular and graphical form.
Table 15 shows the mean difference, for each 
condition, between the holistic overall quality-of-
care rating (based on a 10-point scale) for hospitals 
classiied as belonging to a higher-mortality group 
or a lower-mortality group. Mean difference is the 
mean score for higher-mortality hospitals minus 
the mean score for lower-mortality hospitals. A 
negative mean difference in the table indicates that 
the lower-mortality group mean score is higher 
than the mean score for the higher-mortality 
group.
The result trends are different for COPD and for 
heart failure. For COPD, quality-of-care scores 
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tend to be higher in the lower-mortality group 
of hospitals than in the higher-mortality group, 
and there is a signiicant difference in the quality 
scores given by the doctors. The signiicant score 
for all three groups of staff (p = 0.033) is likely to 
be driven by the signiicant score for the doctors 
groups (p = 0.012). These indings might be 
thought of as being in an expected direction, 
although research shows that process–outcome 
relationships are by no means straightforward.38
For heart failure, there are smaller mean 
differences in a negative direction, indicating that 
quality-of-care scores are higher in the higher-
mortality hospital group. However, the differences 
are quite small and none of the differences are 
signiicant.
It is dificult to interpret the indings in Table 15 
overall – there is certainly no overall trend to 
higher quality scores in lower-mortality hospitals. 
It may be that the contrasts are an example of the 
unexpected indings found by other researchers 
(e.g. Gibbs et al.7), where higher quality-of-care 
scores have been found among patients with poorer 
outcomes.
The holistic overall care review data in Table 15 
are also presented as box plots in Figures 9 and 
10 to demonstrate the distribution of scores from 
individual reviewers (identiied in the tails of the 
distributions by anonymous review numbers), 
together with medians and interquartile ranges, for 
the two hospital mortality groups.
Table 16 shows the mean difference for the mean 
of the total percentage scores from the criterion-
based reviews for each condition for the higher- 
and lower-hospital mortality groups. These are not 
dissimilar indings from Table 15, with many of the 
criterion scores tending to be higher in the lower-
mortality group of hospitals. In this analysis there 
is also only one signiicant difference found, but, 
this time, it is in the physician reviewers’ score for 
heart failure – a higher quality score for the lower-
mortality hospital group.
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Overall, there does tend to be a higher quality 
score for criterion review in the lower-mortality 
hospitals. However, note that when contrasting the 
results of Tables 15 and 16, the reviewers were using 
implicit judgements to score care in Table 15, but 
there were explicit standards set through the review 
criteria in Table 16. Judgement-based holistic scale 
scoring tends to show larger ‘tails’ at both ends of 
scoring than criterion scoring, which is unlikely to 
be inluenced by outcome (Figures 9 and 10). For 
‘poor’ care at the individual case level, reviewers 
using holistic methods can be very critical, as some 
of our textual data show, and the reverse is the case 
for good care.
The criterion-based review data that are presented 
in Table 16 are also shown in Figures 11 and 12.
)HHGEDFNWRVWXG\KRVSLWDOVDQG
WHDPV
Following the completion of the reviews, each 
reviewer received a feedback report containing 
their own data. Individual hospitals or reviewers 
were not identiied in the report. The report 
contained summary statistics and frequencies for 
the algorithmic criterion and the holistic quality-
of-care scores for all phases of care and the quality-
of-records element of the review. The holistic 
quality-of-care scores were compared with those 
from other reviewers reviewing the same records. A 
mean quality-of-care score was calculated for each 
hospital and this was also provided in the report. 
Appendix 6 contains an example report that has 
been anonymised.
Each reviewer received an electronic copy of the 
report, as it was envisaged that the report would 
provide a useful basis for local audit presentations. 
Where requested, individual assistance was 
provided to reviewers wishing to present their 
data at local audit meetings. For example, advice 
was given on the meaning of the data or speciic 
graphs/tables were produced in POWERPOINT.
From the feedback we received from the reviewers 
about the reports, most found the reports to be 
useful and interesting.
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Retrospective assessment of the quality and safety 
of care primarily depends on review of information 
from the clinical record, and the literature suggests 
that both holistic and criterion-based review 
methods make valuable contributions, but both also 
have methodological limitations.
This is the irst study in the UK that has compared 
the two methods of review and it has additionally 
contrasted the results of three different professional 
groups. Few international studies have contrasted 
the review results of different professional groups 
using the same methods, although Weingart et al.6 
compared the results of explicit (criterion-based) 
review undertaken by nurses with implicit review 
of the same record undertaken by physicians. They 
found that when examining medical records ‘nurse 
and physician reviewers often came to substantially 
different conclusions’.6 Key results from our study 
include:
• Reviewers are reasonably internally consistent.
• There is some evidence of moderate to good 
within-group reliability for holistic review.
• All three professional groups were good at 
criterion review.
• There is evidence of agreement between the 
results of holistic and criterion review in the 
hands of physician reviewers.
• The is some difference in review focus between 
nurses and physicians.
Our most important research questions have 
been, irst, to determine the level of agreement 
between health-care professionals, from different 
backgrounds, when they review the same record. 
This agreement, or reliability, relates to the 
repeatability of the results from the review – 
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whether a different reviewer would come to the 
same conclusion about the quality of care from the 
same data source, using the same method. This is 
clearly a practical question, as well as a research 
question. Second, we have used review of the same 
record to explore the relationship between holistic 
and criterion-based methods.
Reviewers undertaking holistic review, using scale 
scores, were relatively consistent in the scores for 
each case note allocated to care quality across the 
individual phases of care and overall for the entire 
episode of care. All three professional groups 
had moderate within-group inter-rater reliability, 
ranging from 0.46 (95% CI 0.34 to 0.59) to 0.52 
(95% CI 0.41 to 0.62). The physician reviewers had 
the highest values. These results were replicated 
for the physician reviewers in the kappa analysis 
(Table 6b), although the kappa scores for the other 
two professional groups were considerably lower. 
The ICC reliability values were rather higher than 
the average found in a systematic review by Lilford 
et al.12 in which, for implicit structured review, 
studies of case note review concerned with causality 
and process of care had kappa values of below 0.4 
[causality: kappa 0.39 (SD 0.19); process: kappa 
0.35 (SD 0.19)].
The inter-rater reliability results of the study 
are also somewhat similar to those of Hofer and 
colleagues,10 who also used ICCs and found a 
reliability of 0.46 for a structured holistic review 
of diabetes and heart failure records by physician 
reviewers (although only 0.26 for COPD records). 
In comparison, a recent holistic assessment of 
patients dying in UK hospitals achieved a kappa 
score of 0.39 on the key indicator of quality of 
medical care.41 Nevertheless, our study found that 
there was still a considerable range of reliability 
scores between individual reviewer pairs, even 
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between the doctor reviewers. This variation might 
be a relection of either training or experience, or 
perhaps it represents other aspects of the causes of 
holistic review variation identiied in the literature, 
such as bias or harshness in reviewing.12–16 It could 
also relect our decision not to train on explicit 
standards of care.
Most of our reviewers had not undertaken a formal 
holistic review before. Training and support was 
provided, but it was deliberately designed not 
to inluence the effect of implicit judgement 
and the training may therefore not have been 
suficient to reduce the element of variation due to 
inexperience with the review methods. The large 
quality and safety review programmes in the USA 
(for example in the Colorado and Utah study5 and 
the study by Daley and colleagues37) use senior 
physician reviewers who have been screened to 
identify and exclude those who may have particular 
biases. This approach might have had a positive 
impact on the inter-rater reliability results, but was 
not an option open to this study because of the cost 
and availability of senior staff.
Completeness of the clinical record is a signiicant 
feature in the success of review methods, as a review 
can only consider what is written in the record and 
reviewers have to depend on the abstracted details 
of the case. Not recording an event does not mean 
that the event did not occur. It may be, for instance, 
that a practitioner did not record the event because 
he/she considered it to be too trivial. However, non-
recording or very limited recording is a deinite 
constraint on the effectiveness of records review as 
a means of assessing quality of care among groups 
of patients. On the other hand, direct observation 
of the quality of care, suggested as an alternative to 
records review,9 would be very expensive if it were 
to be used as a standard procedure. Nevertheless, 
reviewers judged the quality of recording in the 
case notes as reasonable (over 4 on a scale of 1–6), 
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although some notable poor exceptions were 
commented on in the textual reviews.
The levels of inter-rater reliability for criterion-
based review ranged from moderate (0.61 for non-
clinical audit staff) to quite high (clinical staff 0.74, 
doctors 0.88), and are similar to those found in the 
large UK national clinical audit programmes of 
stroke care24,25 and continence care.42 All three staff 
types performed equally well at capturing criterion-
based data from records, despite differences in 
their backgrounds, again conirming the indings 
of the UK stroke care audit.24,25 It is unsurprising 
that criterion-based review has higher levels of 
inter-rater reliability than holistic review, as the 
criteria are predetermined, directly evidence based, 
have been subject to peer review and are explicit 
rather than implicit. Under these circumstances, 
an ICC of less than 0.75 might be deemed 
unsatisfactory and any large study using explicit 
criteria might best train reviewers with this target 
in mind.
Criterion-based review demonstrated that the 
reviewers from all three groups could identify 
relevant data where it existed (the effectiveness 
of reviewer scores were around a mean of 95%), 
and that, in general, suficient case note data were 
available from which to assess quality of care using 
the review criteria. The quality-of-care scores for 
both criterion-based review and from holistic review 
using overall scale scores were similarly rated by 
the three staff types at between 70% and 79% (Table 
10), where 100% represents excellent care.
We found that in the hands of medically trained 
and of non-clinical audit reviewers, although not 
for the nurse and other clinical group, there was a 
signiicant level of agreement between the results of 
holistic and criterion-based review, suggesting that 
the two methods are measuring related elements 
of quality. This may have important implications 
for the choice of review method when evaluating 
the quality of care from case notes. Criterion-based 
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review methods may give suficient information 
on which to judge the overall quality of care, 
performing as a screening tool for large clinical 
audit studies, provided that the appropriate review 
criteria are chosen. On the other hand, a structured 
form of holistic review, such as described here, can, 
in the right hands, also give a reliable picture of the 
quality of care and pick up the nuances of quality 
variation that criterion-based review is unable to 
provide.
:KDWDGGLWLRQDOFRQWULEXWLRQ
GRHVKROLVWLFWH[WXDOGDWDPDNH
WRWKHDVVHVVPHQWRITXDOLW\RI
FDUH"
Although there was some overlap between the 
results from the three professional groups, across 
the spectrum from descriptive statements to 
judgements, some distinctive patterns also emerged 
(Tables 11 and 12, and Box 5). It is not surprising 
that, in general, the reviewers without any clinical 
training tended to provide mainly descriptions 
of care process and only relatively rarely offered 
judgements on quality. The nursing group offered 
some judgements, especially about process or 
care issues, and in general were more concerned 
about the nursing process and the care plan than 
about the interventions offered to the patient. The 
doctors, on the other hand, were in general more 
concerned with assessing the quality and safety of 
the therapies, and strategies for dealing with the 
acute illness rather than about the overall care 
plan.
Nurses tend to be close to the hospital medical 
care process because of frequent contacts with the 
patient, so it might have been expected that the 
results from the nursing/clinical staff reviewers 
might have been close to those of the medical 
reviewers. But the limited agreement between the 
doctors and the nurses may also relect different 
internal professional standards for assessing 
quality and safety of care when reviewing a 
record. Weingart and colleagues6 conjectured that 
nurses and doctors reviewed in different ways – 
that nurses sought data on the routines of care, 
whereas doctors looked for a wider picture – and 
that, in general, neither group considered both 
dimensions. Analysis of the textual data tends to 
support the notion that the doctors and nurses in 
this study commented on different aspects of care 
when assessing quality. Judgements by the nurses 
tended to be implicit rather than explicit and they 
tended towards reviews of nursing process of care. 
Doctors were the group who tended to mention 
outcomes or impact on future care, more so than 
the other groups, on the whole using explicit 
statements. Some were willing to justify why they 
thought care was good or unsatisfactory. Our results 
suggest that the hypothesis posited by Weingart et 
al.6 may have some validity – in reviewing quality of 
care, nurses tend to concern themselves with care 
processes and pathways, while doctors tend to be 
concerned with diagnosis and interventions. Each 
professional type may therefore identify nuances of 
care that the other does not.
Mean review times for both methods were quite 
similar for the doctor and nurse reviewers and 
the costs for the doctor group were consequently 
higher for each review. The cost differences 
between the nurse reviewers and the doctor 
reviewers were rather less for holistic review than 
for criterion-based review. So the decision on 
which reviewer type to use for a review process will 
principally depend on which type of information 
is required from the review, though with an eye to 
the cost differentials. Because the cost of analysis 
of the textual data is high and requires specialist 
skills, and because there is some evidence from the 
relationship between criterion review and holistic 
scale score data, it is likely that any large-scale 
study using holistic review would use scale scores to 
judge quality of care, rather than a full textual data 
analysis. On the other hand, for smaller scale, more 
detailed studies, analysis of textual commentary 
on quality of care provides a very rich data set on 
which to judge quality and safety.
Examination of the more than 100 reviews of cases 
judged to be unsatisfactory shows very few deined 
adverse events, the commonest of these being 
decisions to give the wrong drug.43 Other, fewer, 
more serious events include missed or erroneous 
diagnoses. Much more commonly in the reviews 
there appear unsatisfactory aspects of care that may 
run as a thread throughout the hospital admission. 
What might be regarded individually as ‘minor 
shortcomings’ on their own become fused together 
to create an ‘event’. These shortcomings do not 
always translate across all of the phases of care. 
Sometimes, for example when care is handed over 
from one team to another, missed diagnoses or 
inappropriate or suboptimal treatment (e.g. not 
following evidence-based practice) is seen to be 
recovered by the receiving team and overall care is 
judged satisfactory. From our study we have been 
able to show that adverse events are at least as likely 
to be non-discrete constellations of suboptimal 
components of care that, taken together, put the 
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patient at risk. Notwithstanding the additional 
costs, narrative descriptions of care through holistic 
analysis can considerably enhance understanding 
of health-care quality and may be of particular 
value in locally based clinical audit.
:KDWLVWKHUHODWLRQVKLS
EHWZHHQPRUWDOLW\RXWFRPHV
DQGTXDOLW\RIFDUHVFRUHVIRUWKH
VWXG\KRVSLWDOV"
In a systematic review of the relationship between 
quality and outcomes of care (risk-adjusted 
mortality) in hospitals or hospital units, Pitches 
and colleagues38 found an uncertain relationship 
emerging from a heterogeneous group of 36 
studies, including 51 quality-and-outcome 
relationships. About one-half of the studies 
demonstrated a link between better quality of care 
and the lower-risk hospitals, about one-quarter 
of studies showed a negative association and the 
remainder were equivocal.
We also found some mixed results (Tables 15 and 
16 and Figures 9 and 10). Across all staff types, 
for holistic review of cases of COPD, there was a 
trend for a positive relationship between higher 
overall quality-of-care scores and a lower mortality 
ranking, with one signiicant difference scored by 
the physician reviewers. For heart failure quality 
of care there was a trend towards higher scores 
in higher-mortality hospitals, although the mean 
score differences were small. For the criterion-
based review there was a general trend towards 
higher quality scores for lower-mortality hospitals. 
For both conditions, it was the results from only 
the nurse/clinical reviewers for COPD, and from 
only the physician reviewers for heart failure that 
showed a positive association with lower mortality.
It is likely that these associations are inluenced 
by review method and staff type, as well as by the 
method of risk adjustment and the actual quality 
of care provided and recorded. It could be argued 
that the differences between hospitals that might 
be found using criterion-based review would be 
(and were) relatively limited because of the very 
structured nature of the criteria. So review criteria 
might be less useful in assessing differences 
between hospital units than the more broadly based 
holistic method. In contrast, triangulation of the 
holistic review intra-rater consistency, inter-rater 
reliability and qualitative analysis results suggests 
that the doctor reviewers, on the whole, produce 
information that does allow judgements about 
quality of care, and that for both COPD and heart 
failure there is a signiicant positive relationship 
between their overall holistic scale scores and 
mortality ranking of the hospitals, suggesting that 
for these two conditions better quality is found in 
hospitals with lower mortality.
Hofer and colleagues10 suggested that inter-rater 
reliability results for chronic diseases, such as 
heart failure and COPD, were, to some extent, 
inluenced by the evidence base, proposing that 
in their study the heart failure reviews had higher 
inter-rater reliabilities than COPD reviews because 
the evidence base for heart failure management 
was stronger than that for COPD. There is room 
for debate on this hypothesis, but, in any event, we 
found that the quality–mortality relationship was 
apparent more consistently across reviewers for 
COPD than for heart failure.
6WXG\OLPLWDWLRQV
In a complex study such as this there are bound 
to be methodological limitations. There were only 
two tracer conditions used in the study, whereas 
comparable studies in the USA have used ive or 
more conditions.10 Additionally, because of the 
nature of the research questions, only 38 reviewers 
in nine hospitals were involved and they came 
from a range of backgrounds, although with some 
similarity to the study by Weingart and colleagues.6 
Results from this study, nevertheless, show enough 
similarities with those from Hofer et al.10 and 
Weingart et al.6 to suggest that they are meaningful.
Assessment of the quality and safety of care using, 
among other methods, a six- or 10-point scale, 
remains unusual in the literature. Evaluation of the 
sensitivity of the scales was not possible prior to the 
main data collection, and, although the intra-rater 
reliability results suggested that there was a fair 
degree of internal consistency when these scales 
were used, further research on the use of similar 
scales would be of value.
There is a potential for bias in the study method 
in that the design, and especially the constraints of 
the ethics and research governance requirements, 
meant that reviewers evaluated the case notes in 
their own hospitals (rather than, for example, 
reviewing the case notes in another hospital, 
where they would not have the possibility of 
reviewing cases in which they may have provided 
care). This is an acknowledged potential bias, 
although the range of holistic scores and the types 
of commentary that were recorded suggest that 
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many of the reviewers were quite robust when 
determining the score for a case.
The reliability estimates reported in this study 
are likely to be larger than the true population 
reliability values because of the sampling method 
used in the design. The variability of the results 
of the holistic reviews, including up to 15% of 
reviews that scored 1 or 2, means that the ICC 
will tend to be higher than if the review results 
had been more homogeneous. Furthermore, the 
ICC ‘combines three features of the data (patient 
variability, reviewer variability and measurement 
variability) from which it is calculated 7 it does 
make comparisons of ICCs between different 
studies dificult to interpret’.44 Nevertheless, a 
recent systematic review of the inter-rater reliability 
reported in case note review studies11 was able to 
make kappa comparisons and this study had higher 
ICC results than the review kappa for both causality 
and process of care [causality: kappa 0.39 (SD 
0.19); process: kappa 0.35 (SD 0.19)].
We have undertaken a relative simple statistical 
analysis to compare the reliability of the holistic 
and criterion-based reviews by using kappa and 
ICC statistics. These statistical methods do not 
allow for other facets of measurement, such as the 
disease or reviewer characteristics. The lack of 
balance in the design precludes a classic ANOVA-
based generalisability analysis to assess reliability. 
However, a multilevel modelling approach could be 
used. We have not been able to undertake this, but 
we acknowledge that such a model might produce 
smaller standard errors and give narrower CI 
estimates for the reliability coeficients. However, 
we believe that this model is unlikely to change the 
conclusions of the study in a substantive way.
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KRVSLWDOOHYHORXWFRPHVRIFDUH"
%DFNJURXQG
The purpose of this second part of the study 
was to investigate how much of the variance in 
risk-adjusted outcome for two important clinical 
conditions could be attributed to differences in 
quality of clinical care in acute hospitals, as assessed 
through review of case notes.
Using case notes as the basis for assessing health-
care quality is known to be problematic for a 
number of reasons, such as reliability,6,10,12,45 bias15 
and consistency,8 even although case notes are still 
almost universally used as a primary data source 
for this purpose. This continuing usage is partly 
due to the fact that the alternatives to using case 
note review as the basis for quality assessment – 
such as direct observation, use of video or actor 
patients – may be even more time-consuming and 
expensive, and they have their own methodological 
challenges. Approaches to reducing uncertainty 
in the measurement of quality of care have been 
concerned with improving reliability in implicit 
review, such as using structured review methods,28 
and providing evidence-based review criteria for 
explicit review.19,21
In addition to measuring the process of care, the 
putative relationship between process and outcome 
is also an important consideration for health-care 
systems and is the subject of scrutiny by public 
bodies.46 Case note review has been used in a 
considerable number of studies to provide process 
of care data in order to explore the relationship 
with outcome of care, a relationship that appears 
complex. This was recently demonstrated by 
Pitches et al.,38 who undertook a systematic review 
of 36 studies, which included 51 ‘process-versus-
risk-adjusted outcome relationships’, exploring the 
extent to which variations in risk-adjusted mortality 
rates were associated with differences in quality of 
care. The authors found a positive correlation in 
only 51% of the relationships, with no correlation 
in 31% and an unexpected correlation in a further 
18%, in what was a very heterogeneous set of 
studies.
In a study of 87,000 surgical operations in eight 
subspecialties in 44 hospitals with a range of risk-
adjusted mortality, Gibbs et al.7 used structured 
implicit review of case notes to populate the 
primary outcome measure of a ive-point scale 
that assessed overall quality of care. Overall, the 
authors found that quality-of-care ratings were not 
signiicantly different between hospitals with higher 
than, and lower than, expected mortality.
National quality-of-care audits in the UK, such 
as the National Stroke Audit,47 have used explicit 
review criteria to assess quality of care. Using a 
60-item set of criteria derived from the UK stroke 
audit in a longitudinal case note review study 
of stroke care in New Zealand, McNaughton 
and colleagues48 found only weak relationships 
between process and outcome variables across four 
hospitals, and the hospital with the best process 
scores had the worst case mix-adjusted outcomes. 
A study of 20 UK maternity units found substantial 
change in practise over 8 years, but few associations 
between proxy outcomes and other explanatory 
variables.49
Earlier in this phase of the study, we considered 
the beneits and limitations of using case notes 
as the basis for reviewing quality of care and 
examined the reliability and value of two review 
methods – holistic (implicit) review and criterion-
based (explicit) review – in the hands of different 
types of health professional. We showed that the 
two methods provide different types of quality 
assessment with reasonable to good levels of 
reliability.
In this next stage of the study, hospital-based 
process of care is assessed using mixed case note 
review methods, with implicit review structured 
by phases of care, including both scale scores and 
structured textual data, together with explicit, 
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criterion-based scores; outcome is judged using a 
set of direct and indirect measures derived from 
national data sets.
6WXG\DLPDQGUHVHDUFK
TXHVWLRQV
$LP
To investigate how much of the variance in 
outcome for two important clinical conditions 
(adjusted for measurable differences in risk) can be 
attributed to known differences in quality of clinical 
care in acute hospitals.
5HVHDUFKTXHVWLRQV
• What is the relationship between the quality 
of care for individual conditions in hospitals 
and overall quality of care and quality markers 
across hospital institutions?
• What is the relationship between case mix or 
risk-adjusted outcome and quality of care as 
measured by case record review?
• Is high-quality care associated with high-quality 
outcomes in risk-adjusted cases?
• Is there a correlation in clinical quality between 
the management of different conditions in 
the same hospital, as measured by case note 
review?
0HWKRGV
&KRLFHRIVHWWLQJVUHYLHZ
PHWKRGVDQGVWDII
6HOHFWLRQRIVWXG\KRVSLWDOV
In our original proposal we indicated that a total 
of 24 acute hospitals in England would contribute 
data to this process–outcome study, including the 
data from with the case note reviews in the initial 
eight (nine) hospitals in the reliability study. During 
the analysis of the irst part of the study, it became 
clear that the method of data collection being 
selected for the outcomes study – using a single 
physician reviewer per condition per hospital and 
a compound method of reviewing – meant that the 
data from the reliability study could not contribute 
fully to the objectives of this outcome study. Thus, 
a total of 24 hospitals were separately recruited for 
this quality and outcomes study.
Selection of the hospitals used the same processes 
in the phase one reliability study. First, Hospital 
Episode Statistics33 on 28-day mortality data for 
COPD and heart failure were accessed through 
the East Midlands Public Health Observatory. 
Hospitals were excluded from the selection process 
if they reported less than 200 inpatient cases per 
year for either condition, effectively excluding 
smaller or specialist acute hospitals. There were 
136 hospitals in the inal data set.
Second, 28-day mortality data for the two study 
conditions for each hospital were combined, using 
simple averaging, to create an average 28-day 
mortality ratio for each hospital. Third, these 
were then ranked from the lowest mortality to the 
highest, and the data was split into four quartiles. 
And, inally, from this ranking, hospitals were 
randomly selected in each of the lowest- and the 
highest-mortality quartiles.
The 20 hospitals selected for the reliability study 
were excluded from the selection process. Thirty 
hospitals were then randomly selected from the 
remaining 116 in the data set – 15 from the lower-
mortality quartile and 15 from the higher-mortality 
quartile. Six additional hospitals over the proposed 
24 were selected to take account of the likely drop-
out rate during the recruitment and ieldwork 
phases of the study.
At the commencement of data collection there were 
25 hospitals included in the study. However, only 
20 hospitals in total, 10 each in the upper- and 
lower-mortality groups, were able to collect data 
on both COPD and heart failure. Thus only 20 
hospitals were included in the overall analysis.
Figures 13 and 14 demonstrate the mortality 
differences between the two groups of hospital 
included in the inal analysis, each mortality group 
(upper and lower) containing 10 hospitals.
6HOHFWLRQRIUHYLHZFRQGLWLRQV
This quality and outcomes study used the same 
two conditions as in the phase one study – namely, 
admissions for acute exacerbation of COPD and of 
heart failure – in each study hospital.
The working deinitions for data collection are 
shown in Box 6.
1XPEHURIFDVHQRWHVIRUUHYLHZDQGRI
UHYLHZV
Analysis of the data from the irst part of the 
study suggested that 40 case notes would be an 
appropriate number to review at each hospital, 
for each condition, in a study that was to seek 
associations between recorded quality-of-care and 
hospital-level outcomes. Furthermore, review of 
40 case notes has been shown in the UK Stroke 
and COPD national audits34,47 to be practical and 
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%2; :RUNLQJGHÀQLWLRQVIRUGDWDFROOHFWLRQ
Deinition of an exacerbation of COPD
$QH[DFHUEDWLRQLVDVXVWDLQHGZRUVHQLQJRIWKHSDWLHQW·VV\PSWRPVIURPWKHLUXVXDOVWDEOHVWDWHZKLFKLVEH\RQGQRUPDO
GD\WRGD\YDULDWLRQVDQGLVDFXWHLQRQVHW&RPPRQO\UHSRUWHGV\PSWRPVDUHZRUVHQLQJEUHDWKOHVVQHVVFRXJKLQFUHDVHG
VSXWXPSURGXFWLRQDQGFKDQJHLQVSXWXPFRORXU
Deinition of an exacerbation of heart failure
$QH[DFHUEDWLRQRIKHDUWIDLOXUHLVDVXVWDLQHGZRUVHQLQJRIWKHSDWLHQW·VV\PSWRPVIURPWKHLUXVXDOVWDEOHVWDWHZKLFKLV
EH\RQGQRUPDOGD\WRGD\YDULDWLRQVDQGLVDFXWHLQRQVHW&RPPRQO\UHSRUWHGV\PSWRPVDUHZRUVHQLQJEUHDWKOHVVQHVV
WLUHGQHVVDQGVZHOOLQJRIWKHIHHWDQGRUDQNOHV
to yield useful data. In contrast with the earlier 
analysis, it was not intended to undertake intra-
rater and inter-rater reliability analyses, so it was 
not necessary for each set of records to be reviewed 
more than once.
In our proposal for phase two of the study we said 
that in order to test the reliability of the review 
process, 10 sets of case notes per condition per 
hospital would be double reviewed (rather than 
double reviewing all case notes). However, this 
,QIRUPDWLRQRQTXDOLW\RIFDUHIURPFDVHQRWHVYVKRVSLWDOOHYHORXWFRPHVRIFDUH

target of 10 double reviews proved not possible, 
partly because of the costs involved in undertaking 
the double reviews and partly because of inability 
to recruit second reviewers of the same staff type, 
beyond the 50 reviewers already required.
&KRLFHDQGUHFUXLWPHQWRIUHYLHZHUV
In our initial research proposal we said that only 
one review method would be used at this stage 
of the project, the choice being made following 
the analysis of the data in the reliability study. 
Analysis of the reliability study showed that while 
there were similarities between the criterion-based 
reviewing skills of the doctor and nurse, there were 
differences in the type of holistic data captured 
by the two professional groups and which formed 
the basis of the judgements about quality-of-care 
scores. Medically trained reviewers tended to judge 
the quality of interventions, whereas nurses tended 
to review from a care pathway perspective. As the 
study reported here sought associations between 
process of care and outcomes of care, it was 
judged that medically trained reviewers in higher-
specialty training were likely to provide the most 
appropriate data.
Following the random selection of candidate 
hospitals, in each hospital a senior physician 
working in cardiology (heart failure care), and a 
senior physician working in COPD care were both 
asked to recruit a physician reviewer in mid-stage 
training in their relevant specialty.
6HOHFWLRQDQGUHÀQHPHQWRIUHYLHZ
PHWKRGV
One of the subsidiary purposes of the earlier 
reliability study was to determine which of two 
review methods was most appropriate for the 
quality-of-care/outcomes study – criterion-based 
review or holistic review. We had found that the two 
methods were complementary, although different, 
and, therefore, that both methods might have a 
value in the review of care for the outcomes study. 
Review of care using evidence-based criterion 
methods would provide information on the 
extent to which care, overall, itted with external 
standards. Structured holistic review with quality-
of-care scores, together with short explanatory 
comments where reviewers thought it appropriate, 
would provide information about the nuances of 
care that could not be identiied through the use 
of preconstructed review criteria. In this second 
part of the study it was not necessary to separate 
out the reviewing stages (holistic review followed 
by criterion-based review), as the results of the 
two methods were not being compared one with 
another, as in the earlier study. It was therefore 
possible to merge the holistic and criterion-based 
reviews into one process, so that the case notes were 
only reviewed once and a single data collection 
form could be used.
Using a form of structured implicit review, the 
reported quality of care provided to each patient 
was scored for each of three phases of care 
(admission/investigations, initial management and 
pre-discharge care) and for care overall.
In the earlier part of the study of holistic review, a 
six-point Likert scale was used by reviewers to rate 
the quality of care in each of the three phases of 
care, together with a 10-point Likert scale that was 
used to rate the overall quality of care. Although 
the 10-point scale was more inely grained, 
comparison in the phase one study between the 
six-point phase scores and the 10-point scale added 
to the complexity of the analysis without providing 
obvious beneits to the structured review process. 
A six-point scale was therefore used for all phases 
and overall care review in this study, with anchors 
of 1 = unsatisfactory and 6 = very best care. The 
descriptors for the six points are shown in Box 7.
%2; 'HVFULSWRUV
 &DUHIHOOVKRUWRIFXUUHQWEHVWSUDFWLFHLQRQHRUPRUHVLJQLÀFDQWDUHDVUHVXOWLQJLQWKHSRWHQWLDOIRURUDFWXDODGYHUVH
LPSDFWRQWKHSDWLHQW
 &DUHIHOOVKRUWRIFXUUHQWEHVWSUDFWLFHLQPRUHWKDQRQHVLJQLÀFDQWDUHDEXWLVQRWFRQVLGHUHGWRKDYHWKHSRWHQWLDOIRU
DGYHUVHLPSDFWRQWKHSDWLHQW
 &DUHIHOOVKRUWRIFXUUHQWEHVWSUDFWLFHLQRQO\RQHVLJQLÀFDQWDUHDEXWLVQRWFRQVLGHUHGWRKDYHWKHSRWHQWLDOIRU
DGYHUVHLPSDFWRQWKHSDWLHQW
 7KLVZDVVDWLVIDFWRU\FDUHRQO\IDOOLQJVKRUWRIFXUUHQWEHVWSUDFWLFHLQPRUHWKDQWZRPLQRUDUHDV
 7KLVZDVJRRGFDUHZKLFKRQO\IHOOVKRUWRIFXUUHQWEHVWSUDFWLFHLQRQHRUWZRPLQRUDUHDV
 7KLVZDVH[FHOOHQWFDUHDQGPHWFXUUHQWEHVWSUDFWLFH
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Two prompting questions had earlier been used 
to seek textual comments on the quality of care, 
but reviewers tended only to respond to one or 
other of the questions. Thus, in this study, only one 
question was asked of reviewers when they provided 
textual comment on the quality of care. Box 8 shows 
the format of the questions used for phases of care 
and care overall.
The quality of care provided was also measured 
through the presence of a condition-speciic 
set of review criteria for each of the two study 
conditions. A number of changes to the earlier 
data collection methods were required to make the 
criteria and data capture tools it for purpose for 
the outcomes study. During the irst phase study 
it became apparent that a limited number of the 
review criteria had far higher levels of missing 
data than other criteria. We presumed that this 
was because the data was routinely unavailable, 
or more dificult to ind, or that the criteria were 
more dificult to understand. Whatever the reason, 
these criteria added nothing to the review process 
and were removed. Additionally, because of the 
potential impact of poor quality recording on the 
ability to assess quality of care, reviewers were asked 
to rank the quality of the information held in the 
clinical records on a Likert scale from 1 (poor) to 6 
(excellent).
Reviewers were unaware of their hospital mortality 
ranking – whether they were in the higher- or 
lower-mortality quartile – and they evaluated the 
records within their own hospital, as would happen 
with a local clinical audit. No patient-identiiable 
data was returned to the study team or used in the 
analysis.
5HYLHZHUWUDLQLQJ
Reviewers were trained to use a combination of 
two forms of case note review – criterion-based 
(explicit) review and holistic (implicit) review – and 
also to provide written critical commentary on 
quality of care received by the patient, including 
on adverse events. The majority of reviewers were 
trained at a seminar in which the review methods 
were presented, using a set of anonymised case 
notes as the basis for small group and larger 
directed discussions. Topics discussed included 
techniques to ind relevant information and group 
discussion to identify good and less satisfactory 
performance from the case notes.
Some reviewers were unable to attend the main 
training sessions and they received one-to-one or 
small group training from study research staff.
6HOHFWLRQRIRXWFRPHGDWD
An a priori choice of outcome measures relevant 
to the study was made by the multiprofessional 
study team. Measures were selected from a range of 
sources, relating to:
• clinical practice measures, such as 28-day 
mortality rates for COPD and heart failure 
(from Hospital Episode Statistics33) and 
patients with myocardial infarction (MI) 
receiving thrombolysis within an hour46
• hospital-level proxy clinical outcome data, 
such as Hospital Standardised Mortality Ratio 
(HSMR)50
• proxy measures of patient safety and safety 
climate, for example from the NHS Staff 
Survey 200651 and the National Patient Safety 
Agency (NPSA),52 used in an evaluation of 
incident reporting levels to the Agency (these 
data items were selected from a larger set as a 
result of previous empirical research)53
• external review data, such the ability of the 
hospital to meet national targets for quality, 
collected by the Healthcare Commission (HCC) 
for England.46
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The inal set of outcome variables is shown in 
Box 9.
$QDO\WLFDODSSURDFK
Quantitative quality-of-care data from holistic scale 
scores and criterion scores were examined using 
summary statistics.
The outcomes data set for each hospital was 
constructed from the data available for each 
hospital on the data sets identiied in Box 9 
(above). For the ranked mortality analyses, data 
were combined for the 10 hospitals in each of the 
higher- or lower-mortality groups.
Correlation of the relationship between the 
quality-of-care (process) data and outcome data 
was undertaken using Pearson’s correlation 
coeficient for continuous data, together with linear 
regression analysis. Multiple regression analysis was 
used where appropriate. Spearman’s correlation 
coeficient was used for ordered categorical data 
(such as quality-of-service ratings). Levels of 
strength of correlation are shown in Box 10.
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All statistical tests were two-sided and a signiicance 
level of p  0.05 was used for all analysis except 
multiple regression analysis, where a level of p ) 0.1 
was used.
Qualitative data from the textual commentary 
was examined by four reviewers, three of whom 
analysed data from 17 reviews each (of 40) to 
ensure some overlap, while a fourth reviewer 
reviewed a further sample of ive from the total. 
Consistency among reviewers was checked after all 
had assessed output from two reviews, followed by 
discussion of the results. Further consistency check 
was undertaken between all four reviewers prior to 
completion of the analysis.
The results of each qualitative assessment of a 
reviewer’s output, in which analysts identiied cases 
being described as excellent, good, satisfactory, 
unsatisfactory or very unsatisfactory, were then 
checked against the overall scale scores to judge 
whether a reviewer’s quantitative scores were 
relected in their qualitative description of the 
quality of care provided for a case.
5HVXOWV
Within the 20 study hospitals, reviews of case notes 
were undertaken of 873 people with COPD and 
692 people with heart failure (1565 in total). The 
numbers of reviews undertaken by each reviewer 
for COPD ranged from 8 to 40 (median 40, mean 
35) and for heart failure from 10 to 49 (median 40, 
mean 35).
Reviewers were asked to assess the quality of 
recording in the case notes because of the potential 
impact of poor-quality recording on the ability to 
assess quality of care. On a scale of 1–6 the quality 
of case notes was scored satisfactory or better in 
85% of the reviews.
5HODWLRQVKLSEHWZHHQRXWFRPH
YDULDEOHVDQGKLJKHUDQGORZHU
PRUWDOLW\JURXSVRIKRVSLWDOV
There were 10 hospitals in each mortality group. 
Table 17 presents the mean scores for continuous 
outcome variables available from national data 
sets (excluding NHS staff survey outcomes) for the 
higher- and lower-mortality groups of hospitals. 
There was a signiicantly higher percentage of both 
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COPD and heart failure patients who died within 
28 days in the higher-mortality group of hospitals 
than in the lower-mortality group of hospitals (as 
would be expected from the hospital selection 
criteria), and the 1-year mortality data available 
from the ‘Dr Foster’ analysis50 was signiicantly 
higher for the higher-mortality group of hospitals.
Additionally, the mean age for heart failure 
patients was signiicantly higher for the higher-
mortality group of hospitals than the lower-
mortality group of hospitals. The differences in 
mortality rates between the two groups of hospitals 
were as expected from the selection criteria for 
those hospitals, so that the results serve to conirm 
the expected differences (see also Figures 13 and 
14). The 1-year mortality data from the Dr Foster 
source also support the expected differences in 
mortality, and the higher mean age of people 
with heart failure in the higher-mortality group 
of hospitals may be a partial explanation for 
those higher mortality rates. No other signiicant 
associations were found.
5HODWLRQVKLSEHWZHHQPRUWDOLW\JURXSV
DQGTXDOLW\RIFDUH
Table 18 shows that most reviewers classify care in 
the good range [about 41% for COPD, and 46% for 
heart failure (score 5)], with around 19–21% in the 
‘fell-short-of-best-practice’ range (score 1–3) and 
the lowest scores (1, unsatisfactory) under less than 
5% for both conditions across the 20 hospitals.
The relationship between the holistic data 
(including mean scale scores for overall care, all 
of the phase of care scores) and the mean total 
criterion score, correlated with the hospital groups 
ranked by mortality, was analysed using the two 
independent samples t-test (Tables 19 and 20). Mean 
difference is the mean score for each case note 
review in the higher-mortality group of hospitals 
minus the mean score for the lower-mortality 
group of hospitals. A negative mean difference in 
the table indicates that the lower-mortality group 
mean score is higher than the mean score for the 
higher-mortality group.
For both conditions the indings are therefore 
consistent. Across all phases of care and overall 
care using holistic review, and total criterion score, 
there was a trend towards higher mean scores for 
the lower-mortality hospital groups. However, when 
account was taken of clustering, there were no 
statistically signiicant differences in scores between 
the two groups of hospitals.
The similarities between the quality-of-care scores 
in the upper and lower hospitals are further 
demonstrated when the relationship between mean 
overall and mean phase holistic scale scores and 
ranked mortality is explored. Tables 21–24 show the 
relationships between holistic scores (ranging from 
1 = unsatisfactory to 6 = very best care) and ranked 
mortality. No signiicant differences in scores were 
found between the upper and lower mortality 
groups of hospitals.
The relationship between the mean holistic overall 
quality-of-care scores for COPD and heart failure 
in each hospital was also explored using a Bland–
Altman plot (Figure 15) to investigate whether the 
two scores tended to be in the same direction in 
each hospital. That is, if the hospital was in the 
lower-mortality group (which, on average, had 
somewhat higher group mean scores for both 
COPD and heart failure) was this pattern replicated 
within each hospital? No clear pattern emerged 
between the two mean scores for each hospital 
when grouped for overall mortality, so that it is 
not possible to see a trend towards higher scores 
for both conditions in each of the lower-mortality 
hospitals, or for the lower scores for each condition 
in each of the hospitals in the higher-mortality 
group.
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Pearson’s correlation coeficient was used for 
analysis of continuous data. Spearman’s correlation 
coeficient was used for analysis of ordered 
categorical data (e.g. HCC star rating). Levels of 
strength of correlation are assumed as in Box 10, 
above.
Rather than using statistical signiicance to identify 
important results, correlations were identiied as 
important if the correlation coeficient was greater 
than 0.4; that is, at least a moderate relationship 
existed between the two variables under 
investigation. Very weak and weak relationships 
(r ) 0.4) were regarded as having no correlation.
There were only a limited number of moderate to 
very strong correlations between the quality-of-care 
scores for the upper- and lower-mortality hospital 
groups and the outcome and risk-adjustment 
variables selected for the study. A positive 
correlation indicates that, as criterion or overall 
holistic score increases, the variable levels also 
increase. Thus, for example, a positive correlation 
for NHS staff survey question 22e (care of patient/
service user is top priority) demonstrates an 
increase in COPD or heart failure criterion score, 
as there is an increase in the mean score for staff 
who agree that care of patient/service user is top 
priority in the hospital.
An example of a negative correlation would 
be an increase in COPD or heart failure score 
that correlates with a decrease in the number 
of incidents reported to the NPSA per 100 bed-
days (increased reporting is thought to indicate a 
positive safety culture53).
Tables 25–28 present the moderate to very 
strong correlations only. The results of all of the 
holistic data correlations, including those without 
statistically signiicant results, are presented in 
Appendices 7–10. Pearson correlation coeficients 
are used unless otherwise indicated in the table. 
Each table is accompanied by scatter plots itted 
with regression lines to demonstrate the strength of 
the correlation.
&23'PHDQKROLVWLFRYHUDOOVFRUH
 XQVDWLVIDFWRU\WR YHU\EHVWFDUH
Table 25 shows that there were only two moderate 
negative correlations. Thus, as the COPD scale 
score increased (an indication of better quality 
of care), the frequency decreased at which NHS 
staff said they were encouraged to report errors 
(Figure 16), and also when staff said that care of the 
patient/service user was a high priority (Figure 17). 
These correlations are in an unexpected direction, 
as better quality of care might have been expected 
to relate to both a positive safety culture and to 
high priority for patient care.
+HDUWIDLOXUHPHDQKROLVWLFRYHUDOOVFRUH
 XQVDWLVIDFWRU\WR YHU\EHVWFDUH
A total of four variables were signiicantly 
correlated with heart failure mean score: quality 
of services, existing national targets, new national 
targets, and NHS staff survey question 24a (know 
how to report concerns) (Table 26).
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There is a strong positive correlation between 
quality of services (fair, good or excellent) and 
heart failure mean score: those trusts with a fair 
score had lower mean heart failure scores than 
trusts with a good or excellent score (Figure 18). 
Existing national targets (partially met, almost met, 
fully met) were also strongly positively correlated 
with heart failure mean scores where an increase 
in mean scores indicated an increased likelihood 
of trusts meeting existing national targets (Figure 
19). There was a moderate positive correlation 
between new national targets (weak, fair, good, 
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excellent) and heart failure – mean heart failure 
scores increased with increased levels of excellence 
(Figure 20).
Finally, there was a moderate positive correlation 
between NHS staff survey question 24a and heart 
failure mean score: the higher the percentage of 
responders who knew how to report incidents, the 
higher was the mean heart failure score (Figure 21).
&23'PHDQKROLVWLFSKDVHVFRUH
Only NHS staff survey question 22e (care of 
patient/service user is top priority) was signiicantly 
correlated with COPD mean holistic score (Table 
27). As with the overall score analysis above (Table 
25), the correlation between the two variables 
was negative, and as COPD mean holistic score 
increases the mean score for care of patient/service 
users being a top priority decreased – a lower score 
indicates more disagreement with the statement 
(Figure 22).
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+HDUWIDLOXUHPHDQKROLVWLFSKDVHVFRUH
Seven variables were signiicantly correlated with 
heart failure mean holistic score:
1. heart failure mean age [Hospital Episode 
Statistics (HES) data]
2. quality of services
3. percentage of patients with acute MI receiving 
thrombolysis
4. existing national targets
5. NHS staff survey question 27e (trust takes 
action to ensure never happens again)
6. NHS staff survey question 24a (know how to 
report incidents)
7. NHS staff survey question 22e (care of patient/
service user is top priority).
Mean age is negatively correlated with score: as 
mean age increases mean holistic score decreases 
(Figure 23). This may be explained by older people 
having more complex problems, although reviewers 
in the phase one study showed that quality of care 
could be scored highly even when a patient did not 
survive.
Quality of service (fair, good, excellent) is positively 
correlated with mean score; thus, as heart failure 
mean phase score increases, the more likely a 
hospital is to be of good or excellent status (Figure 
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24). There is a moderate positive correlation 
between the percentage of patients with acute MI 
receiving thrombolysis and heart failure mean 
holistic phase score (an important association in 
heart failure care) (Figure 25). A strong positive 
correlation exists between existing national targets 
(partly met, almost met, fully met) and heart failure 
mean holistic phase score, mean scores increase as 
the level of meeting targets increases (Figure 26).
Additionally, there were moderate positive 
correlations between mean score for NHS staff 
survey questions 27e and 22e and heart failure 
mean holistic phase scores – the higher the heart 
failure score, the stronger the respondent agreed 
with the statement that the hospital takes action 
to ensure that it does not happen again or care 
of patient/service user is top priority (Figure 27). 
Finally, there was a moderate positive correlation 
between NHS staff survey question 24a and heart 
failure mean holistic phase score, where the higher 
the percentage of responders agreeing (% yes) they 
know how to report incidents results, the higher 
the heart failure mean holistic score (Figure 28).
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Tables 29 and 30 show the relationships between 
criterion scores and mortality grouping. There 
were no statistically signiicant differences in mean 
scores per mortality group. These indings are 
similar to the holistic quality-of-care data (Tables 
21–24).
&RUUHODWLRQVEHWZHHQFULWHULRQEDVHG
VFRUHVDQGRXWFRPHYDULDEOHV
Correlations at the moderate to very strong level 
are shown in Tables 31 and 32, with accompanying 
scatter plots. The results of all correlations are 
presented in Appendices 11 and 12.
COPD mean criterion score (out of 13)
Two variables were signiicantly correlated with 
COPD mean criteria score: incidents reported 
to the NPSA per 100 bed-days and NHS staff 
survey question 22f (happy with standard of 
care provided) (Table 31). A moderate negative 
correlation was observed with NPSA bed-days, 
as the number of incidents per 100 bed-days 
decreased the mean criteria score increased 
(Figure 29). Again this is an unexpected direction 
for the correlation, as increased reporting is a 
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positive safety culture marker. A moderate positive 
correlation was observed with NHS staff survey 
22f (mean score), where the higher the score, 
the happier the staff with their standard of care; 
thus, as the mean response to 22f increased, mean 
COPD score increased (Figure 30).
Heart failure mean criteria score (out 
of 11)
Two variables were signiicantly correlated with 
heart failure mean criteria score: incidents 
reported to the NPSA per 100 bed-days and NHS 
staff survey question 24b (knowing the system for 
reporting errors) (Table 32). In a reversal of results 
from the COPD criterion analysis there was a 
signiicant positive correlation between incidents 
reported to the NPSA and heart failure mean score, 
as the number of incidents increased the mean 
heart failure score increased (Figure 31). There 
was also a strong positive correlation between 
the percentage of responders to the NHS staff 
survey stating they did not know how to report 
errors conidentially and mean heart failure score. 
That is, as mean heart failure score increased, the 
percentage of responders reporting that they did 
not know how to report concerns also increased 
(Figure 32).
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2XWOLHUVLQWKHDQDO\VLV
It was agreed to identify which hospitals were 
outliers in each analysis to establish whether it 
was the same hospital each time. The following 
outliers were identiied (hospital scores presented 
in parentheses):
• COPD mean holistic overall score – hospital 
RC9 (2.9)
• Heart failure mean holistic overall score – 
hospital RN1 (3.1)
• COPD mean holistic phase score – hospital 
RQW (10.2)
• Heart failure mean holistic phase score – no 
outlier identiied
• COPD mean criterion-based score – no outlier 
identiied
• Heart failure mean criterion-based score – 
hospital RNH (9.3), hospital RQW (7.0).
Hospital RNH (from the heart failure criterion 
score analysis) was the most noticeable outlier in 
all analyses and a decision was taken to rerun the 
analysis to see if there were any changes in the 
correlation results.
There were some minor differences in results 
following the exclusion of hospital RNH. Incidents 
reported to the NPSA remained moderately 
correlated with heart failure mean score: the 
higher the number of incidents, the higher the 
mean heart failure score. The percentage of heart 
failure patients dying in hospital within 28 days 
moderately correlated with heart failure mean 
score: the lower the percentage of patients who 
die within 28 days, the higher the mean score. 
Finally, NHS staff survey question 24b [system for 
reporting error (% replying that they did not know 
of the system)] is no longer strongly correlated with 
mean heart failure score.
5HJUHVVLRQDQDO\VLV
A priori, one of the objectives of this analysis was to 
it multiple regression models to COPD and heart 
failure scores to establish any predictors. With a 
sample of 20 hospitals the number of variables in 
a multiple regression model should be restricted to 
two, as anything over two would result in overitting 
a model. Furthermore, consideration should be 
taken of categorical variables such as existing 
national targets, where each level of response (not 
met, partly met, almost met, fully met) counts as 
one variable in the regression analysis – thus a 
categorical variable with three or more categories, 
which is the case for all categorical variables in this 
data set, would result in overitting.
It was possible to it a multiple regression model 
for COPD criterion score, where NPSA incidents 
and NHS staff survey question 22f (happy with 
standard of care provided) were signiicant 
predictors of COPD score at the 10% signiicance 
level. A one-unit increase in the number of 
incidents reported to NPSA per 100 bed-days 
resulted in a 0.5 decrease in COPD criterion score, 
and a one-unit increase in the staff who were happy 
with standard of care resulted in a 3.14 change 
in COPD score. Multiple regression models were 
itted using the forwards stepwise method, by which 
the most signiicant variable at the univariate stage 
is selected irst.
When the regression model was itted to the COPD 
criterion score, this model included only the two 
variables that were signiicantly correlated with 
the score. When included in a regression model 
together, neither ‘incidents per 100 bed-days’ nor 
‘NHS staff survey question 22f ’ were signiicant at 
the 5% signiicance level (Table 33).
A multiple regression model was also itted 
to heart failure criterion score, where NPSA 
incidents and NHS staff survey question 22f were 
signiicant predictors of heart failure score at the 
10% signiicance level. A one-unit increase in 
the number of incidents reported to NPSA per 
100 bed-days resulted in a 0.21 increase in heart 
failure criterion score, and a one-unit increase in 
the percentage of staff reporting ‘no’ to system for 
reporting errors resulted in a 0.11 change in heart 
failure score.
When a regression model was itted to the heart 
failure criterion score, this model included only 
the two variables that were signiicantly correlated 
with criterion score. When included in a regression 
model together, incidents per 100 bed-days was no 
longer signiicant when included with NHS staff 
survey question 24b (percentage of staff reporting 
they did not know of the system) (Table 34).
For the remaining four analyses it was not possible 
to it a multiple regression model, either because 
no two variables were signiicant in the same model 
or due to problems with overitting for categorical 
variables.
'LVFXVVLRQ
This part of the study set out to explore how much 
of the variance in outcome for two important 
clinical conditions (COPD and heart failure) can be 
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attributed to differences in quality of clinical care 
in acute hospitals. The main indings of the study 
were:
• Within-hospital and between-hospital variation 
in quality of care can be identiied from 
a combination of holistic scale scores and 
criterion-based review.
• While there were trends towards hospitals 
having lower mortality also having higher 
quality-of-care scores, none of these differences 
was statistically signiicant.
• Although there were some correlations between 
quality-of-care scores and hospital-level 
outcome data, there was no clear relationship 
between the quality of care and hospital-level 
outcomes for the two indicator conditions in 
this study. This may relect the complexity of 
the process–outcome relationship at the patient 
group level.
• Available hospital-level outcome indicator data 
are probably insuficiently sensitive to relect 
the quality of care recorded in patient case 
notes. Furthermore, the nuances of patient care 
may mean that high-quality care may be given 
even when the patient’s outcome appears poor, 
and vice versa. These indings may be pointing 
to process measures as being more useful than 
outcome measures when reviewing the case 
notes of people who have chronic disease or 
multiple conditions.
The study explored a complex methodological 
and clinical question, and the extent to which it 
can be investigated is dependent on a number 
of factors, which, in this study in particular, are 
related to the available outcome measures and the 
availability of process of care measures. Choice of 
outcome measure can be critical in exploring the 
relationship between the process and outcome of 
care. For example, the death of a patient (outcome) 
in the terminal stages of a chronic illness may not 
be inluenced even by the highest quality of care 
(process).
Previous studies have already indicated that the 
relationship between process and outcome is 
dificult to assess, and the systematic review by 
Pitches et al.38 found that only about one-half of 
the 51 correlations between process measures and 
outcome indicators in the 36 studies were positive.
Process (or quality-of-care) measures in this study 
were derived from a multimethod case note 
review process that was reined during phase one 
of the study. For each case, reviewers produced a 
synthesis of their perspective on the quality of care 
provided, rather than from direct observation. 
Only the quantitative data from holistic scale scores 
and criterion-based scores could be used for the 
analysis, with the holistic textual data being used 
to validate the reviewer’s holistic scale scores being 
given to overall and phases of care.
Condition-speciic mortality and proxy outcomes 
were derived from a range of hospital-level data. 
These measures were selected from a much more 
extensive list through a process of group discussion, 
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drawing also on the research team’s experience 
in another study that examined the inluence of 
hospital-level process and outcome measures on 
incident reporting in acute hospitals.53 Resource 
constraints and the dificulties of obtaining 
research governance and patient consent meant 
that, although desirable, it was not possible to 
obtain patient-level outcome data for the 1565 
cases reviewed.
In seeking to explore the relationship between 
the quality of care for the two tracer conditions in 
hospitals and overall quality of care and quality 
markers across hospital institutions, we found 
only a limited number of positive associations. 
Correlations with continuous outcome data, where 
positive (Table 17), mainly relected the selection of 
mortality to group the hospitals.
In exploring the relationship between quality-
of-care scores and hospital mortality group, the 
indings are consistent for both conditions. Across 
all phases of care and overall care using holistic 
review, and total criterion score, there was a trend 
towards higher mean scores for the lower-mortality 
hospital groups (Tables 19 and 20). However, when 
account was taken of clustering by reviewer, there 
were no statistically signiicant differences in scores 
between the two groups of hospitals. These results 
are supported by the inding that there are no 
statistical differences for the mean holistic scale 
scores between the higher- and lower-mortality 
hospitals (Tables 21–24).
If the quality of care is good for one condition 
in a hospital, as measured by case note review, 
should we expect that it will also be good for 
another condition? From each hospital there were 
approximately 40 reviews available for the quality 
of care in COPD and in heart failure (80 reviews 
in total). It might be hypothesised that a hospital 
from the lower-mortality group might be expected 
to have higher quality-of-care scores and that the 
levels of quality of care for the two conditions 
within each hospital bear some relationship. We did 
not ind this – in general, scores were only slightly 
higher in the lower-mortality group than in the 
higher-mortality hospital group. Analysis (Figure 
15) shows that there is little association within 
hospitals, and we are unable to show that better 
quality care results in better quality hospital-level 
outcomes.
We explored the relationships between holistic 
and criterion-based quality-of-care scores on 
the one hand and hospital-level process and 
outcome indicators on the other. These indicators 
were drawn from a number of sources, and their 
relationship with the outcome of quality of care for 
the two conditions took different forms. Some, such 
as the HCC indicators, were related to the general 
external reference measures. Others, particularly 
from the NHS staff survey, are known to be related 
to safety culture and incident reporting.53
There are a number of positive correlations in 
the expected direction for holistic scale score and 
mean phase score data, although this is mainly for 
heart failure – there are only limited correlations 
for COPD holistic data. However, there were also 
a number of negative correlations for which it is 
dificult to ind an explanation. For example, as 
COPD mean holistic score increases, the mean 
score for care of patient/service users being a top 
priority decreased. It is possible that some of these 
associations are chance indings because of the 
number of correlations being undertaken. However, 
we limited this effect by ensuring that all statistical 
tests were two-sided, with a signiicance level of 
p ) 0.05, and weak and very weak associations were 
excluded from consideration in the analysis.
Why is the correlation between recorded process 
and outcome so apparently poor? We have 
already indicated that the methods may not be 
sophisticated enough to measure the associations. 
It may be that the use of hospital-level measures 
that are not condition speciic, and that relect 
the organisation as a whole, are too abstract for 
the purpose of assessing care for people with such 
conditions such as COPD and heart failure.
However, there may be other important 
confounding issues that relate to the meaning of 
quality of care and to the relationship between 
process and outcome when quality of care is 
measured.
When Mohammed and colleagues27 explored 
the care of people with stroke, they found, as 
we did, that both criterion and holistic methods 
are valuable in reviewing care, and others have 
suggested similar approaches. They also found 
that clinical practice issues, such as the impact of 
advance directives, made it dificult to assess quality 
unless detailed information at the patient level 
was used to understand outcomes. In our study it 
became clear that reviewers could be very critical 
of quality of care and were willing to make explicit 
judgements about clinical practice. Crucially, 
though, reviewers were able to say that what might 
be regarded as a poor outcome (e.g. a patient died) 
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can be accompanied by very high-quality care. 
For a very ill patient, with little of no chance of 
surviving, high-quality palliative care may be both 
appropriate and in the patient’s and family’s best 
interests. Alternatively, patients may survive very 
poor care. Again, choice of outcome measure is 
critical.
Nevertheless, although individual level data 
may increase the likelihood of deining process–
outcome relationships, this still remains a 
methodological challenge. When Gibbs and 
colleagues7 used patient-level outcomes as well 
as hospital-level outcomes to investigate the 
relationship between process and outcome among 
surgical patients, they found that people who were 
more severely ill, or who died or had complications, 
had higher quality-of-care ratings than those with a 
lower predicted outcome risk. Furthermore, Pitches 
et al.38 have shown that numbers of studies ind 
uncertain relationships between process and risk-
adjusted outcomes of care. The results of this study 
seem to be following a similar trend.
/LPLWDWLRQV
Because of a lack of proven methodologies for 
chronic disease care, and because of the dificulty 
of accessing individual outcome data, it was 
not possible to undertake a full risk-adjusted 
analysis. Whereas Daley et al.37 were able to access 
a number of possible predictors for surgical care, 
these are mainly unavailable for chronic disease 
management. In this study, the availability of the 
outcome measures was limited to hospital-level 
data and it has not been possible to capture more 
individual-level data. This is clearly a potential 
limitation. However, even though risk adjustment 
measures have been available for the assessment of 
the effect of process of care on surgical outcomes, 
a number of studies have found it dificult to 
show positive associations between risk-adjusted 
mortality and good quality of care.7,37,54,55
Reviewers are not perfect. For instance, some may 
have a more positive view on cases than they should 
have, or be too inexperienced to identify laws in 
care. Nevertheless, we have no evidence that they 
glossed over errors, as they did identify about 20% 
of cases that fell into the unsatisfactory range and 
about 4% that were identiied as adverse incidents 
or near misses. The ability to judge the quality of 
care provided is also dependent on the quality of 
recording in the case notes, and there may not be 
enough data in the records to be able to make an 
adequate judgement on quality of care – although 
reviewers indicated that about 85% of the case 
notes were in a satisfactory or better condition.
Although the two groups of hospitals in this study 
had considerable differences in mortality rates 
between the lower-mortality hospitals and the 
higher-mortality hospitals, a whole range of factors 
might account for those differences, such as case 
mix and age. Indeed, in this study, there is some 
indication that quality-of-care scores went down as 
age went up in the group of heart failure cases, but 
this may be because of higher levels of mortality 
risk before admission. We do not know enough 
about these cases to model this risk, although we 
did randomly select the 10 hospitals in each group.
We did not account for any measurement error 
in the process variables and the number of 
measurements per hospital. As the correlation of 
true scores is equal to the correlation of observed 
scores divided by the square root of the product of 
their reliabilities, it is possible that measurement 
error may dilute the magnitude of the correlation 
coeficients. This means that the correlations 
observed between the process and outcome 
variables may be lower than the true population 
correlation.
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To return to our practical research question, what 
do our results tell us about which method of review 
would be best used for which purposes and by 
which professional groups? We have found that 
all three professional groups perform well when 
using criterion-based review. If this type of review 
is chosen, perhaps for large-scale clinical audit to 
inform service development, the decision on which 
professional groups should undertake reviews using 
this method might depend mainly on cost and 
availability of staff. The data on resource use show 
that the doctors are considerably more expensive 
at cost per review, because they have the highest 
salary levels, although their review times are similar 
to the nursing/clinical group. However, medically 
trained reviewers may have a place when using 
structured review methods to identify variations 
in care, such as adverse events, as clinical training 
might be of advantage by enhancing watchfulness. 
Furthermore, review of small numbers of cases has 
relatively little cost impact, and for criterion-based 
review of limited numbers of cases, for example in 
an investigation of quality of care, staff with nursing 
or medical training may add value to an evaluation.
The decision on who should undertake structured 
holistic review is more complex. It is a method 
that might best be used when more is required 
than just the sum of the results of collecting a set 
of review criteria. While all groups can use the 
method of holistic-scale scoring, the overall results 
conceal wide ranges of agreement, sometimes 
close to random for phase-of-care results (Table 
7). Particularly for the more technical phases of 
care, such as investigations, admissions and initial 
management, these results suggest that the three 
groups of staff are interpreting the recorded 
care differently when they each review the same 
record. This probably relects their background 
knowledge of the clinical situation and of how the 
care is delivered. Even when considerable training 
in the review method has been provided, it is 
unrealistic to expect the non-clinical audit staff to 
fully appreciate the details of the medical care, let 
alone when that care has or has not deviated from 
best practice. Results suggest that nursing-trained 
reviewers sometimes identify different problems 
from those found by physician reviewers. It is 
possible that extended training and selection of 
staff might reduce this difference, for instance by 
selection of specialist consultant nurses or of very 
experienced doctors. Selection of person skills 
according to task might provide the best outcome 
for the more dificult reviews.
Moreover, reviews of cases of serious unintended 
incidents or of poor-outcome cases might beneit 
from structured reviews by pairs of reviewers – one 
with a nursing background and one with a medical 
background. Our results have shown that these 
two groups of reviewers offer different types of 
results, with nurses tending towards care process 
issues and doctors offering judgements on more 
technical interventions. If reviews were supported 
by effective training, including the enabling of staff 
to make explicit judgements on care, joint mixed 
professional reviewing, perhaps using more senior 
doctors and consultant-level specialist nurses, 
might offer a wider range of insights than if case 
records were reviewed by two professionals from 
the same background. Whereas Weingart et al.6 
wondered whether the differences in holistic review 
results from physicians and nurses reviewers could 
be problematic, the differences we found in our 
study could be put to a positive advantage.
Textual data provides much iner-grained 
information than do scores or criterion-based 
review, even when it is provided in short phrases 
and sentences. Full analysis of the textual data 
in a clinical setting, rather than in a research 
project, is likely to be costly and dificult to do 
when undertaking large-scale audits or quality and 
safety reviews. However, the increasing practice 
of undertaking smaller scale reviews, for example 
where there are a small series of cases with poor 
outcomes that require detailed review, is identifying 
a need for structured reviews that would beneit 
from a combination of data, such as is provided 
by criterion-based scores, holistic scoring and 
structured textual commentary.
Overall, the results of this study suggest that there 
may be signiicant gains to be made in clinical 
audit and evaluation through better understanding 
2YHUDOOFRQFOXVLRQVRIWKHUHVHDUFK
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of the products of the different methods of review 
and of the value in training and selection of 
reviewers.
5HYLHZLQJXVLQJDPL[HGPHWKRG
DSSURDFK²KRZFDQLWEHXVHGLQ
IXWXUH"
Because of the research aims of the irst part of the 
study, we separated out the review methods into 
two distinct sections – holistic and criterion based. 
In the second part of the study, those methods were 
combined to provide holistic scale scores, criterion-
based scores and textual data about the quality 
of care of each of the phases and of overall care. 
Here, the textual data was used only to validate 
the holistic scale score data. Results suggest that 
when reviewing or auditing small groups of cases, 
for example when there are concerns about the 
outcome of interventions, mixed holistic and 
criterion-based review, which also captures textual 
data, may prove a powerful model. In using these 
mixed methods, careful attention will be required 
to aspects such as the selection and training of 
reviewers, including recognition of the problems 
associated with inter-rater reliability and bias.
5HODWLRQVKLSVEHWZHHQ
TXDOLW\DQGRXWFRPHRIFDUH
No strong relationships were found between quality 
of care, as measured by case note review, and 
outcome of care at the hospital level. Other authors 
have found a similar lack of direct association. The 
inding that reviewers considered quality of care as 
a broad concept, where patients who fared poorly 
overall because of their underlying condition 
might nevertheless have high-quality care, relects 
a similar inding by Gibbs et al.,7 when examining 
patient-level outcomes; in their study, patients with 
poor outcomes or with a higher predicted risk of 
mortality or morbidity had higher quality-of-care 
ratings than those with a low predicted risk of 
adverse outcome. Mohammed and colleagues27 
found that a combination of holistic data and 
criterion-based data was required to understand 
the inluence of care on outcomes, and Pitches et 
al.38 concluded from their systematic review of the 
literature that ‘the general notion that hospitals 
with higher risk-adjusted mortality have poorer 
quality of care is neither consistent nor reliable’.
Lilford and colleagues56 have recently provided 
a useful critique of risk-adjusted outcomes in the 
assessment of health-care quality in which they 
question the value of using outcome measures 
to evaluate the quality of care. We are unable to 
conirm their proposition to use process measures 
rather than outcome measures with our results, but 
would suggest that for the purposes of reviewing 
quality of care, process measurement that allows for 
an integration of both criterion-based and holistic 
review can provide a sound basis for decision-
making.
Meanwhile, the real challenge of outcomes is 
to deine what is measurable – and there are 
actually few measures that are validated.57 Where 
attempts have been made to develop outcome 
measures, there has been some tendency for 
health professionals to dismiss outcomes as too 
dificult to use. But patients are concerned with 
the ultimate outcome of their therapy and thus we 
cannot ignore the need for appropriate measures, 
and risk adjustment methods, for chronic disease 
management. In the meantime, however, given the 
lack of agreement on speciic outcome measures, 
we suggest that process measures are a reasonable 
proxy.
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Senior clinical staff are increasingly called upon to assess quality of care from case notes under 
conditions in which there is cause for concern. This 
research has identiied three aspects of case note 
review that could be used to support quality review 
and that could beneit from further research.
1. Research to assess the inter-rater reliability 
among experienced physician reviewers, 
including the effect of selection and training. 
This research should take account of other 
work from North America that has shown the 
potential for major discrepancies in inter-rater 
reliability.
2. Reviewer recruitment appears to be dificult in 
the UK, perhaps because this form of clinical 
review has been treated in an ad hoc fashion to 
date. A qualitative study could be undertaken 
to understand the possible barriers and factors 
that might enhance recruitment and training 
of clinician reviewers.
3. Doctors and nurses may view quality differently, 
but there has been no UK research (and little 
international research) to explore whether 
experienced physicians and experienced 
specialist nurses review in a similar or 
complimentary manner (possibly enhancing 
the overall scope and quality of reviews).
4. Research on the reliability of structured holistic 
assessment of the quality and safety of care 
using scales remains unusual in the literature. 
Evaluation of the sensitivity and internal 
consistency of these methods would be of value.
5. The extent to which review criteria are 
reproducible remains a research question. 
There is some evidence from US and UK 
studies using the RAND appropriateness 
method that panels constructing review criteria 
from the same clinical guideline have only 
moderate levels of agreement. The extensive 
need for review criteria generated by national 
clinical guidelines suggests that further 
research could be useful before these criteria 
become a signiicant part of the new quality-
improvement programmes.
There is an important research agenda relating 
to linkage between process and outcome data 
for chronic disease care, and in relation to case 
note review. Although the potential for data 
retrieval from electronic records is considerable 
(information might be gathered from data mining 
and natural language programming), this agenda 
relates to paper-based records, which will remain 
the main data source in hospital care over the next 
5 years.
6. There is a need for further research to explore 
risk-adjusted outcome measure methodologies 
for chronic diseases. Methods of risk prediction 
should be developed in a fashion that enables 
the production of (at least some) measures 
across the spectrum of chronic disease, allowing 
better methods of outcome comparison.
7. There is a continued need for validated 
condition-speciic outcome measures for a 
range of chronic diseases, of a type that can 
be used in health services evaluation – that is, 
comprising a minimum data set of items that 
might, in future evaluations, be collectable 
through electronic records systems.
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This study was undertaken by two partner organisations: the University of Shefield – the 
School of Health and Related Research (ScHARR) 
and the Department of Information Studies – and 
the Royal College of Physicians Clinical Evalation 
and Effectiveness Unit (CEEU). An important 
feature of the study was the contact made with 
clinical teams in over 30 hospitals in England, 
many of whom went on to contribute to the study. 
CEEu staff took a major part in enabling the 
Shefield team to contact the hospitals and their 
specialist teams, as well as providing expertise in 
case note review and quality-of-care methodology.
Karen Beck provided administrative support at 
the University of Shefield throughout the project 
and her contribution was exceptionally helpful. 
In particular her substantial contribution to the 
development of data collection software was 
invaluable.
Jon Nicholl provided valuable methodological 
advice in the early part of the study.
We especially wish to acknowledge the enthusiasm 
and assistance of reviewers and all of their 
colleagues in the study hospitals, without whom 
this study could not have taken place.
We thank the external referees for their 
contributions to shaping the future research 
agenda.
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&23'UHYLHZFULWHULD
1,&(GHÀQLWLRQRIDQH[DFHUEDWLRQRI&23'
ICD–10: J42, J43, J44. ‘An exacerbation is a sustained worsening of the patient’s symptoms from their 
usual stable state, which is beyond normal day-to-day variations, and is acute in onset. Commonly reported 
symptoms are worsening breathlessness, cough, increased sputum production and change in sputum 
colour.’32
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OHIWYHQWULFXODUV\VWROLFG\VIXQFWLRQ
ICD–10: I50.0, I50.1, I50.9, I11.0. ‘An exacerbation of heart failure is a sustained worsening of the 
patient’s symptoms from their usual stable state, which is beyond normal day-to-day variations, and is 
acute in onset. Commonly reported symptoms are worsening breathlessness, tiredness and swelling of the 
feet and/or ankles.’23
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The scenarios used stroke care as exemplars in order not to inluence the views of 
the reviewers on what they might perceive as 
appropriate care for either of the two tracer 
conditions – COPD or heart failure.
0UV;²VFHQDULR
Mrs X, a 78-year-old lively lady, has a dizzy turn 
and for an hour loses the use of her right arm 
and feels weakness in her right leg. She has had a 
transient ischaemic attack (TIA) and goes to her 
GP, very concerned. He gets her an outpatient 
appointment at her local hospital for two months’ 
time. A week after she has seen him she suffers 
a completed stroke (involving her right side and 
speech) and is taken to hospital, where she is 
admitted to a general medical ward. It is a Friday. 
She is seen by a consultant on the following 
Tuesday. She has a CT scan on the Thursday. 
She develops pneumonia on the Friday, which 
is treated. She is referred the following week to 
a geriatrician. She is eventually sent home very 
disabled, no information is sent to her GP, and 
there proves to be a long wait for community 
rehabilitation, so after 2 weeks she is sent to a 
nursing home where she dies after 3 months.
4XDOLW\FRPPHQWV
This lady showed early signs of a pending stroke, 
which could have been prevented.
• No early diagnosis is made and no rapid 
referral to a specialist service is provided.
• No aspirin is prescribed to prevent the stroke.
• No specialist care in a stroke unit.
• There is a delay in providing a CT scan,
• Dysphagia (dificulty swallowing) is not picked 
up by early screening, leading to pneumonia.
• She does not receive early therapy input to 
begin rehabilitation and mobilisation.
• The communication systems between hospital 
and community fail.
• The community services are unable to provide 
the rehabilitation she needs.
0UV;²VFHQDULR
Mrs X, a 78-year-old lively lady, has a dizzy turn 
and for an hour loses the use of her right arm and 
feels weakness in her right leg. She has had a TIA 
and goes to her GP, very concerned. He gets her 
an appointment for the TIA clinic in 2 days’ time 
and starts her on aspirin. At the TIA one-stop 
clinic she is duplex scanned and referred for early 
carotid endarterectomy, which she has within 10 
days. She returns home on appropriate secondary 
prevention, having received dietary advice to 
eat more healthily. She was a lifelong smoker 
so has been given cessation advice and nicotine 
replacement therapy. She continues with her active 
life, with regular follow-up visits to her GP.
4XDOLW\FRPPHQWV
Evidence shows that the danger of stroke is high 
after a TIA.
• She receives appropriate rapid referral to a 
specialist service.
• Secondary prevention with aspirin is 
commenced immediately.
• Early investigations are carried out.
• Appropriate surgical treatment is provided 
quickly.
• Secondary prevention and lifestyle advice are 
provided prior to discharge.
• Her health is monitored regularly by her GP.
0U<²VFHQDULR
Mr Y is a 60-year-old man. He has a rapid-onset 
stroke on a Saturday and is taken to his local 
hospital. Because the hospital CT scanner does 
not work over the weekend, he is booked for a 
scan later in the week but this is cancelled for 
emergency admissions and somehow never gets 
rebooked. There is no acute stroke unit and, with 
the rehabilitation stroke unit being full, he is sent 
to the acute medical admissions ward. There he is 
not screened for dysphagia so his problems with 
swallowing are not picked up and no protocol 
begins. He also develops pneumonia after a week. 
$SSHQGL[

Because of his incontinence he is catheterised in 
the acute medical unit and the catheter remains in 
situ when he is sent to the general medical ward 
and somehow gets left there. He is visited by the 
physiotherapist for his pneumonia and begins 
mobilising for half an hour per day when his 
pneumonia has resolved. Mobilising is also made 
more dificult by his catheter, the fact that he feels 
so weak from not eating properly and following 
the pneumonia. Other complications arise from 
his catheter. He spends many weeks in hospital 
and eventually is sent home, catheter still in situ 
because he has persisting incontinence from poor 
bladder tone that he developed from prolonged 
catheterisation. He remains weak and increasingly 
disabled. No rehabilitation continues at home and 
after a year he suffers a second stroke from which 
he does not recover. The family feel he had poor 
care and are making a complaint through the 
HCC.
4XDOLW\FRPPHQWV
• A CT scan is never carried out.
• He does not receive specialist care in a stroke 
unit.
• His dysphagia (dificulty swallowing) is 
not picked up, leading to pneumonia and 
malnutrition.
• Prolonged, possibly unnecessary, use of a 
catheter leads to complications.
• No early supported discharge from hospital is 
offered.
• No rehabilitation is provided on his return to 
primary care.
0U<²VFHQDULR
Mr Y is a 60-year-old man. He has a rapid-onset 
stroke on a Saturday and is taken to his local 
hospital. There, despite it being a weekend, he 
has a CT scan, from which ischaemic stroke is 
conirmed. He is admitted directly to the acute 
stroke unit. He is attached to monitoring systems 
(oxygen levels and ECG) by specialist nurses, who 
take regular observations of his vital signs (blood 
sugars, temperature, etc.). His clinical assessment 
on arrival in the unit, which includes a swallow 
screen, identiies that he has dysphagia. He is 
designated ‘nil by mouth’ and tube feeding is 
begun by the nurses, using the protocol agreed 
with the stroke team. The speech and language 
therapist sees him on the Monday to begin 
treatment and his dietary regime comes under 
the guidance of the specialist dietitian. He is 
incontinent of urine in the irst 48 hours, which is 
conservatively managed, without catheterisation, 
and resolves spontaneously. The physiotherapist 
begins his early mobilisation regime, which the 
nurses practice with him. An occupational therapy 
referral is made and therapy begins within 1 
week of referral. After a fortnight the secondary 
prevention regime is established (aspirin having 
been started on the second day), using a protocol 
based on the national clinical guidelines for stroke. 
Because Mr Y is anxious to get home by this stage 
he has been referred to the specialist stroke Early 
Supported Discharge team and, once it is clear that 
he can safely get himself out of bed, he goes home 
under their care for continuing rehabilitation at 
home.
4XDOLW\FRPPHQWV
• A CT scan is carried out early, conirming the 
diagnosis.
• Secondary prevention with aspirin is 
commenced early.
• Hospital care is provided in a specialised stroke 
unit.
• He receives regular monitoring of physiological 
indicators while in hospital.
• Dysphagia is identiied early and managed, 
reducing the risk of pneumonia and 
malnutrition.
• Urinary incontinence is managed without the 
need for a catheter (this is associated with 
better clinical outcome).
• Mobilisation therapy is begun early and 
monitored (this is one of the key features of 
stroke units associated with better clinical 
outcome).
• Early supported discharge by a specialist 
team is deemed suitable and is provided (this 
is proven to result in the same outcomes as 
hospital rehabilitation and is liked by patients).
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$SSHQGL[
5HFRUGUHYLHZIRUVDIHW\DQGTXDOLW\VWXG\
A report of the record reviews undertaken by reviewer XXXX. A collaborative project by the Royal College 
of Physicians and the University of Shefield.
)RUHZRUG
Medical record review has become a standard means of assessing variations in quality of care. This is 
despite uncertainty about which methods of record review are most effective and reliable. The aim of 
this audit was to assess which are the most effective and appropriate methods of reviewing quality of care 
from medical records. Further work is currently being undertaken to test out the conclusions and to assess 
whether it is possible to demonstrate a linkage between quality of care and outcomes.
All possible safeguards to preserve the quality of the data collected have been made by the University of 
Shefield. Nevertheless it is important to interpret your results in this report using your knowledge of your 
own service and any dificulties you experienced in collecting your audit data that may have affected your 
own outcomes.
We are grateful to everyone who has helped with the project and appreciate the very considerable amount 
of time and effort that has gone into obtaining local data. We very much hope that this information will be 
useful for local audit purposes.
,QWURGXFWLRQ
Nine hospitals took part in this irst phase of the audit. Overall, 1484 textual record reviews and 
1400 criterion-based record reviews were returned to the study team. Records were reviewed from two 
specialties: COPD and heart failure. Reviewers were either nurses, non-clinical audit staff, SpRs or other 
clinical staff.
This report presents the results of the audit of COPD records undertaken by reviewer 5732. Textual 
reviews were undertaken on 38 out of 50 records, and criterion-based reviews were undertaken on 36 out 
of the same 50 records. Reviews are of patients admitted with an exacerbation of COPD, and who had a 
primary diagnosis of COPD, during the time period 1 September 2004 to 28 February 2005.
0HWKRGV
• Textual review – quality of care is assessed using the reviewer’s own professional opinion.
• Criterion-based review – quality of care is assessed using a set of speciic criteria.
A phases-of-care approach was adopted for both review methods. For textual review, reviewers were asked 
to comment on the care received by the patient in the admission, initial management and pre-discharge 
phases. They were then asked to make a inal overall comment. Reviewers were also asked to rate each the 
quality of care in phase on a six-point scale and to rate the quality of the overall care on a 10-point scale.
For criterion-based review, criteria were grouped under the phase-of-care headings used in the holistic 
review. Reviewers were asked to answer the questions using information from the patient record.
7UDLQLQJIRUGDWDFROOHFWRUV
Two training days were held for data collectors. The training days were both held in London (Royal 
College of Pathologists and BMA House).
$SSHQGL[

The training provided an introduction to the review methods and familiarised the reviewers with the 
materials to be used while undertaking the reviews (data collection software and review help notes). There 
were also sessions on recognising care-quality variance when using the two review methods. For these 
sessions, examples were used from stroke care. This was so that we did not inluence reviewers’ perceptions 
of care quality for the two audit conditions. When reviewers were unable to attend a training day, two of 
the project team visited their hospital and provided training on-site. Reviewers who were unable to be 
present during the site visit were trained via telephone. Where possible, these reviewers were also assigned 
a ‘buddy’ (someone at their hospital who had undertaken the training in a face-to-face setting).
• Fifteen reviewers were trained at the training days.
• Ten reviewers were trained during a site visit.
• Fourteen reviewers were provided with telephone training.
The project team were available throughout the data collection period to answer queries and provide 
support and advice.
3DUWLFLSDQWV
Nine hospitals took part in the COPD audit and eight of those hospitals also took part in the heart failure 
audit. Hospitals were randomly selected to participate in the audit, and consultants at each hospital were 
approached to provide their approval for the audit to take place and to assist in inding staff to review 
records.
The COPD audit involved the following reviewers:
6WDIIW\SH 1XPEHURIUHYLHZHUV
'RFWRU 
1XUVH 
1RQFOLQLFDODXGLWVWDII 
&OLQLFDORWKHUHJSK\VLRRUSKDUPDFLVW 
7RWDO 
The heart failure audit involved the following reviewers:
6WDIIW\SH 1XPEHURIUHYLHZHUV
'RFWRU 
1XUVH 
1RQFOLQLFDODXGLWVWDII 
&OLQLFDORWKHUHJSK\VLRRUSKDUPDFLVW 
7RWDO 
'DWDUHWXUQ
Reviewers were asked to review 50 heart failure or COPD records, using each of the review methods 
(resulting in 100 record reviews). If all reviewers had returned all reviews, this would have resulted in a 
total of 3900 reviews.
However, not all reviewers were able to return the full amount of reviews. This was for a variety of reasons, 
for example staff changing jobs. This was particularly a problem for the SpR reviewers, some of whom 
rotated to a post in a different hospital during the audit period. Also, there were some dificulties in 
recruiting reviewers in some hospitals. This meant that these reviewers started the audit later than other 
reviewers and, as such, had less time to complete all the reviews. Due to work pressures, one hospital site 
was unable to return any heart failure reviews.
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3HUFHQWDJHRIGDWDUHWXUQHG
&RQGLWLRQ 5HYLHZW\SH
7RWDOQXPEHURIUHYLHZV
UHWXUQHG 5HYLHZVUHWXUQHG
&23' 7H[WXDO  
&23' &ULWHULRQEDVHG  
+HDUWIDLOXUH 7H[WXDO  
+HDUWIDLOXUH &ULWHULRQEDVHG  
7RWDO  
7H[WXDOGDWD
We are using the textual data from the holistic review to investigate whether different staff types (e.g. audit 
staff, nurses and specialist registrars) make different types of comment or comment on different issues 
when asked to review quality of care from patient records.
Each reviewer’s comments have been coded according to the type of comment, i.e. whether the comment 
is a judgement of the care provided or a description of the care provided. Comments have also been 
coded according to whether the comment relates to the patient records or patient care. We will use this 
information to determine which type of reviewer (SpR, nurse, non-clinical audit staff) provide the most 
useful types of comments about quality of care.
In some hospitals, different types of staff have reviewed the same records. This is so that we can compare 
the comments to gain an understanding of the types of comments made by different staff. All of the 
analysis has been anonymised and each reviewer is only identiiable by their reviewer ID.
This analysis is ongoing. We hope to publish the results of the study indings and will provide you with 
details of any publications.
5HVXOWV
The following results relate to a review of 38 holistic and 36 criterion-based patient records by reviewer 
5732.
.H\GDWD
Gender
Q 3HUFHQW
)HPDOH  
0DOH  
7RWDO  
Number of patients accepted on to an early discharge scheme
Q 3HUFHQW
1RWDFFHSWHGRQWRDQHDUO\GLVFKDUJHVFKHPH  
1RWDSSOLFDEOH  
$FFHSWHGRQWRDQHDUO\GLVFKDUJHVFKHPH  
7RWDO  
$SSHQGL[

Number of patients discharged or died
Q 3HUFHQW
'LVFKDUJH  
'LHGIURP&23'RU
FRPSOLFDWLRQVRI&23'
 
1RWUHFRUGHG  
7RWDO  
Number of patients with previous admissions for COPD
Q 3HUFHQW
1RSUHYLRXVDGPLVVLRQVIRU
&23'
 
3UHYLRXVDGPLVVLRQVIRU
&23'
 
7RWDO  
+LVWRU\DQGSDWLHQWFKDUDFWHULVWLFV
Smoking status
Q 3HUFHQW
&XUUHQWVPRNHU  
([VPRNHUVWRSSHGPRUH
WKDQPRQWKV
 
/LIHORQJQRQVPRNHU  
1RWUHFRUGHG  
7RWDO  
Social circumstances
Q 3HUFHQW
/LYHVDORQHZLWKVRFLDO
VHUYLFHVXSSRUW
 
/LYHVDORQHQRVXSSRUW  
/LYHVLQQXUVLQJUHVLGHQWLDO
KRPH
 
/LYHVLQZDUGHQFRQWUROOHG
VKHOWHUHGKRXVLQJ
 
/LYHVZLWKVSRXVHFORVH
UHODWLYHRUFDUHU
 
7RWDO  
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$GPLVVLRQSKDVH


4XDOLW\RIFDUHUDWLQJVIRUWKHDGPLVVLRQSKDVH
)UH
TX
HQ
F\




  
 XQVDWLVIDFWRU\
 YHU\EHVWFDUH
Please note, some of these results are subjective and are the opinions of the individual reviewers.
5DWLQJVFDOHUHVXOWVTXDOLW\RIFDUHUDWLQJVIRUWKHDGPLVVLRQSKDVH
Quality-of-care rating for the admission phase – all reviewers from site 439
5HYLHZHU
0HDQTXDOLW\RI
FDUHUDWLQJ 6' 0HGLDQ 5DQJH
    ²
    ²
    ²
    ²
Quality-of-care rating for the admission phase – all hospitals
+RVSLWDO 0HDQ 6' 0HGLDQ 5DQJH
+RVSLWDO    ²
+RVSLWDO    ²
+RVSLWDO    ²
+RVSLWDO    ²
+RVSLWDO    ²
+RVSLWDO    ²
+RVSLWDO    ²
+RVSLWDO    ²
+RVSLWDO    ²
&ULWHULRQEDVHGUHYLHZ²DGPLVVLRQSKDVH
Level of breathlessness
Q 3HUFHQW
,QFUHDVHG  
1RWLQFUHDVHG  
7RWDO  
$SSHQGL[

Level of sputum
Q 3HUFHQW
,QFUHDVHG  
1RWLQFUHDVHG  
1RWUHFRUGHG  
7RWDO  
Changes in sputum colour
Q 3HUFHQW
&KDQJHG  
1RWFKDQJHG  
1RWUHFRUGHG  
7RWDO  
Sputum colour
Q 3HUFHQW
1RVSXWXP  
1RWUHFRUGHG  
:KLWHRUJUH\  
<HOORZRUJUHHQ  
7RWDO  
Was the dyspnoea rating recorded?
Q 3HUFHQW
1R  
<HV  
7RWDO  
Performance status
Q 3HUFHQW
/LPLWHGDFWLYLW\EXWVHOIFDUH  
/LPLWHGVHOIFDUH  
1RUPDODFWLYLW\  
1RWNQRZQ  
6WUHQXRXVDFWLYLW\OLPLWHG  
7RWDO  
Chest X-ray within 24 hours?
Q 3HUFHQW
1R  
<HV  
7RWDO  
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4XHHQ·V3ULQWHUDQG&RQWUROOHURI+062$OOULJKWVUHVHUYHG
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If yes, is X-ray report in notes?
Q 3HUFHQW
0LVVLQJ  
1R  
<HV  
7RWDO  
Respiratory rate within 24 hours?
Q 3HUFHQW
<HV  
1R  
7RWDO  
If yes, irst reading is:
Q 3HUFHQW
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Blood gases within 24 hours?
Q 3HUFHQW
1R  
<HV  
7RWDO  
$SSHQGL[

ECG performed?
Q 3HUFHQW
1R  
<HV  
7RWDO  
Urea recorded?
Q 3HUFHQW
1R  
<HV  
7RWDO  
Serum albumin recorded?
Q 3HUFHQW
1R  
<HV  
7RWDO  
Record of medications at admission?
Q 3HUFHQW
1R  
<HV  
7RWDO  
If peripheral oedema present, was it:
Q 3HUFHQW
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Temperature at admission
& Q 3HUFHQW
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Spirometry reading this admission?
Q 3HUFHQW
1R  
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Record of peripheral oedema?
Q 3HUFHQW
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4XDOLW\RIFDUHUDWLQJVIRUWKH
LQLWLDOPDQDJHPHQWSKDVH
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  
 XQVDWLVIDFWRU\
 YHU\EHVWFDUH
,QLWLDOPDQDJHPHQWSKDVH
5DWLQJVFDOHUHVXOWV²TXDOLW\RIFDUHUDWLQJVIRUWKHLQLWLDOPDQDJHPHQWSKDVH
Please note, some of these results are subjective and are the opinions of the individual reviewers.
Quality-of-care rating for the initial management phase – all reviewers from site 439
5HYLHZHU
0HDQTXDOLW\RI
FDUHUDWLQJ 6' 0HGLDQ 5DQJH
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Quality-of-care rating for the initial management phase – all hospitals
+RVSLWDO 0HDQ 6' 0HGLDQ 5DQJH
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Were antibiotics prescribed?
Q 3HUFHQW
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Were nebulised bronchodilators prescribed?
Q 3HUFHQW
1R  
<HV  
7RWDO  
Did patient receive systemic corticosteroids?
Q 3HUFHQW
1R  
<HV  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Number of arterial blood gas results
Q 3HUFHQW
  
  
  
  
  
  
  
7RWDO  
pH less than 7.35 at any time?
Q 3HUFHQW
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3UHGLVFKDUJHSKDVH
5DWLQJVFDOHUHVXOWV²TXDOLW\RIFDUHUDWLQJVIRUWKHSUHGLVFKDUJHSKDVH
Please note, some of these results are subjective and are the opinions of the individual reviewers. 
Quality-of-care rating for the pre-discharge phase – all reviewers from site 439
5HYLHZHU
0HDQTXDOLW\RI
FDUHUDWLQJ 6' 0HGLDQ 5DQJH
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Quality-of-care rating for the pre-discharge phase – all hospitals
+RVSLWDO 0HDQ 6' 0HGLDQ 5DQJH
+RVSLWDO    ²
+RVSLWDO    ²
+RVSLWDO    ²
+RVSLWDO    ²
+RVSLWDO    ²
+RVSLWDO    ²
+RVSLWDO    ²
+RVSLWDO    ²
+RVSLWDO    ²
&ULWHULRQEDVHGDXGLW²SUHGLVFKDUJHSKDVH
Oximetry within 48 hours of discharge?
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Assessment of home circumstances?
Q 3HUFHQW
1R  
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Where was patient discharged to?
Q 3HUFHQW
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Discharge letter to primary care team?
Q 3HUFHQW
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If yes, is there a clear list of medications?
Q 3HUFHQW
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Type of consultant at discharge?
Q 3HUFHQW
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TXDOLW\RIFDUHUDWLQJVIRUWKHRYHUDOOFDUH
Please note, some of these results are subjective and are the opinions of the individual reviewers.
Quality-of-care rating overall – all reviewers from site 439
5HYLHZHU
0HDQTXDOLW\RI
FDUHUDWLQJ 6' 0HGLDQ 5DQJH
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Overall quality-of-care rating – all hospitals
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$SSHQGL[
&23'²FRUUHODWLRQVEHWZHHQKROLVWLFPHDQ
RYHUDOOVFDOHVFRUHVDDQGRXWFRPHYDULDEOHV
9DULDEOH
&RUUHODWLRQ
FRHIÀFLHQW SYDOXH 5HODWLRQVKLS
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UK stroke care tends to have structured medical 
records for hospital inpatients, with prospective 
completion of patient records based on 
structured phases of care, in some units. This, it 
is hypothesised, changes the type and quality of 
data collected in the medical record and thus may 
more accurately enable conformance with, and 
assessment of, good care standards.
It is currently unknown whether the use of 
structured medical records has any effect on the 
quality of information available for peer review, or 
whether it might differentially inluence the quality 
of information that is captured by explicit or 
implicit review methods. It may also be that there is 
a higher level of inter-rater reliability to be found 
between, and within, types of reviewers when using 
structured, prospective record-keeping compared 
with that found in the main research project.
Major national sentinel audit projects in the UK 
have already used review criteria-based, explicit 
review methods to explore quality variance in 
stroke care.1 These were undertaken by teams 
of nurses or physicians who had been trained in 
records review methods. Substantial variations in 
organisation and clinical care have been identiied 
across the 8200 cases included in the national 
stroke audit. The audit did not use a holistic 
approach, which has been hypothesised as an 
alternative means of identifying quality variation, 
especially in complex cases.2
6WXG\TXHVWLRQV
This small adjunct study seeks to answer two 
related questions. First, what are the similarities 
and differences in peer-review information 
captured by explicit (review criterion-based) 
methods and implicit (holistic) methods from 
structured (stroke care) clinical records? Second, 
are there differences in the type of information 
recorded by clinical audit staff (including nurses) 
and by doctors, using the two types of review 
methods?
This study is nested within the main medical 
records study, which addresses similar research 
questions, but in which the records are not 
structured. Although the stroke care study is small, 
the overall results of the stroke care study can 
therefore be contrasted with the non-structured 
record results in the phase one study to begin to 
explore whether there are differences between the 
type of information that can be extracted from the 
two different types of records.
6HFRQGDU\VWXG\TXHVWLRQV
• Does structured prospective medical record-
keeping in stroke care inluence the type, 
extent and quality of data recorded in clinical 
audit review (compared with the type and 
quality of data found in unstructured record-
keeping in the phase one study)?
• When using explicit (review criteria-based) 
clinical audit review methods, does the use of 
structured recording in stroke care change the 
proportions of recorded criteria compared 
with the proportions recorded in unstructured 
records for COPD and heart failure care?
• For both explicit (review criteria-based) and 
implicit (holistic) clinical audit case note 
review methods, does reliability improve 
between and within reviewer types when 
structured recording is used in comparison to 
unstructured recording?
0HWKRGV
The overall research approach was to investigate 
the impact of structured prospective record-
keeping on the reliability and completeness of 
holistic and criterion-based case note review 
methods. Quality of care was assessed using a 
combined holistic and algorithmic method, as used 
in the phase two outcomes study, by one nursing-
trained reviewer and two medical reviewers. The 
same case notes were reviewed by each reviewer.
6WURNH
Stroke is recognised as the third biggest cause of 
death in the UK. It is also the largest single cause 
$SSHQGL[
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of severe disability in older people. In excess of 
110,000 people in England each year will suffer 
from a stroke, which incurs NHS costs of over  
£2.8B per year.3 All hospitals that care for patients 
with stroke were required to have a specialist 
stroke service by 2004, as set out by the National 
Service Framework for Older People.4 To support 
our choice of stroke for this adjunct study, we 
took into account the availability of an evidence-
based guideline produced by the RCP, together 
with the existence of the National Sentinel Stroke 
Audit.1 The National Sentinel Stroke Audit Criteria 
provided the basis for developing a set of review 
criteria for safety and quality assessment for stroke 
management for this study (see also the section on 
criterion development in Chapter 2).
Number of case notes for review
Each reviewer was asked to review 40 stroke care 
records, as in the phase one study.
Selection and recruitment of hospitals
Only one hospital participated in this small study. 
This hospital was chosen because of the study 
team’s close links with the stroke care staff, whose 
input was crucial to the development of the review 
criteria and the running of the study. A second 
hospital was also approached, but, although they 
were keen to participate, they did not have staff 
available to take part.
Numbers and types of review and 
reviewers
Two doctors in training (SpRs) and one clinical 
audit nurse were recruited to review 40 records of 
patients admitted to hospital for care for an acute 
stroke.
Holistic review data capture
Holistic review data was collected using the same 
methods as in the phase one study. Reviewers were 
asked to provide a textual comment on the quality 
of care and also to rate the quality of care on a 
six-point rating scale (1 = unsatisfactory, 6 = very 
best care). This was done for each of three phases 
of care (admission, initial management and pre-
discharge) and for care overall. Care overall was 
rated on a 10-point rating scale (1 = unsatisfactory, 
10 = very best care).
Assessing the quality of recording in 
the case notes
Evaluation of quality of care through case note 
review is critically dependent on the quality of 
recording in the case notes, together with that 
in associated data sources, such as computerised 
pathology and radiology results. In order to assess 
the quality and completeness of the records under 
review, reviewers were asked to assess the quality 
of each record using a six-point rating scale 
(1 = inadequate, 6 = excellent), as per the main 
study.
Review criteria development for stroke 
care
The basis for the development of the review criteria 
was an already established criterion-based audit 
data set within the National Sentinel Stroke Audit, 
an organisational and clinical audit comprising 
94 criteria. We developed a shorter version of the 
clinical component of the national audit data set 
through discussions with stroke care staff, using the 
same approach as the phase one study.
For the stroke study criterion-based questions, 
predeined answer options were provided for all 
questions. Usually, the options were ‘yes’, ‘no’ 
and ‘not recorded’. Reviewers were instructed to 
answer ‘yes’ if the care was provided or the result 
of a test was in the patient record, and ‘no’ if the 
care was not provided for a valid reason. Examples 
of valid reasons were provided for each question 
and included things such as if the patient died, 
or was unconscious or was receiving palliative 
care. Reviewers were instructed to answer ‘not 
recorded’ if the information they were looking for 
was missing from the record. Where information 
is missing from the record it is presumed that care 
was not provided.
Developing data capture tools
Data collection materials were developed in 
Microsoft ACCESS© and were designed to be easily 
used by the reviewers. The software had a facility to 
easily export formatted data to the study team.
Staff training
Where possible, we intended that staff reviewing 
records for the stroke care study should attend one 
of the training days for the main study, although 
only the nursing-trained clinical reviewer was able 
to attend the training day. The two doctors were 
unable to attend due to clinical commitments, so 
one attended a one-to-one training session with the 
study project manager, while the other was trained 
via telephone by the project manager.
Analysis methods
Holistic scale score analysis
Summary statistics for the holistic quality-of-care 
ratings were calculated for each reviewer, for the 
phases of care and overall data. Box-and-whisker 
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plots comparing the quality-of-care ratings for the 
phases of care and overall quality of care for each 
reviewer were also produced.
Measuring reliability between reviewer pairs
The reliability between the reviewers overall 
quality-of-care ratings was assessed by calculating 
intraclass correlation coeficients (ICCs) in SPSS. 
ICCs were calculated for each reviewer pair (doctor 
1 versus doctor 2, doctor 1 versus clinical audit 1, 
and doctor 2 versus clinical audit 1), as well as a 
combined ICC for all three reviewers.
Criterion-based review
The score for each criterion was summed to create 
quality-of-care scores for each phase of care and 
overall. Summary statistics for the criterion-based 
quality-of-care score were calculated, as were box-
and-whisker plots comparing the three reviewers’ 
data.
Measuring reliability between reviewer pairs
Intraclass correlation coeficients were used to 
assess the inter-rater reliability of the criterion-
based quality-of-care scores. As with the holistic 
reliability analysis, ICCs were calculated for each 
reviewer pair and for all three reviewers.
Ethics review
The ethics review was the same as that for the main 
studies.
Health-care governance
Although the main study had already received 
ethical approval, further discussions were held 
with the clinical effectiveness manager of the study 
hospital to determine whether this small adjunct 
study was research, clinical audit or service review.5 
Ethical principles were considered, following the 
decision that this work would be undertaken as 
service review and conducted in line with local 
governance procedures.
5HVXOWV
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Completeness of data capture
Each of the doctor reviewers reviewed 37 out of 
the 40 records and the clinical reviewer reviewed 
40 out of 40 records. Only the 37 reviews that 
were reviewed by each of the three reviewers were 
included in the analysis. The level of completeness 
of holistic review was assessed by calculating the 
amount of missing data for each of the quality-of-
care rating scales. The amount of missing data for 
each phase for each reviewer is presented in Table 
35 which shows that the completeness level of the 
holistic rating scale is high. One reviewer (1733, 
Clinical) had no missing data. The amount of 
missing data for this section of the review is small. 
The most missing data was recorded by Doctor 1 
for the Initial Management Phase, however, 8.8% 
missing data equates to 3 instances of missing data.
Quality of care
Table 36 presents the results of the quality-of-care 
analysis of stroke care using a holistic rating scale, 
where 1 = unsatisfactory care and 6 = very best care. 
On the whole the reviewer mean/median results 
were similar for each phase of care. Doctor 2 tends 
to rate the quality of care lower than the clinical 
reviewer and doctor 1, particularly in the pre-
discharge section. The clinical reviewer uses only a 
limited section of the rating scale (between 3 and 
5), whereas the other two reviewers (doctors) tend 
to use all of the available scale.
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Box-and-whisker plots of holistic scale 
score data (Figure 33)
The box-and-whisker plots compare the median 
quality-of-care scale rating and the interquartile 
range, for each reviewer, for each phase of care.
Reliability between reviewers
Table 37 presents the results of the stroke care 
holistic review inter-rater reliability analysis and 
shows the level of agreement between reviewers for 
the overall quality-of-care ratings.
Comparison with results from the main 
study
The pair of doctor reviewers achieves the highest 
reliability. This is in line with indings from the 
main study, which found that pairs of doctor 
reviewers achieved the highest reliability for holistic 
review. The phase one reliability study also found 
that there was low reliability between different-staff-
type reviewer pairs, for example ‘doctor and nurse’ 
for holistic review (see Table 7, p. 21). This inding 
is supported by the analysis of the stroke data as 
the different-staff-type reviewer pairs achieve lower 
ICCs here.
The amount of comparison that can be undertaken 
between the stroke reviewer reliability analysis and 
the main study reviewer pair reliability analysis 
is limited, due to the small number of stroke 
reviewers taking part. The doctor reviewer pair 
ICC is similar to that of the COPD doctor reviewer 
pair in the phase one reliability study (0.328 
versus 0.33, respectively – Table 37). In this much 
smaller study on stroke care the different-staff-type 
reviewer pair reliability comparisons are generally 
much lower than those presented in Table 6a (p. 20)
in the phase one study.
&ULWHULRQEDVHGUHYLHZ
Completeness of data capture
Each reviewer completed 37 reviews (of the 
same patient records). Where a reviewer did not 
select one of the predeined answer options for 
each criterion, this was classed as missing data. 
The results in Table 38 show that there are very 
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low missing data rates for all reviewers for the 
criterion-based data collection.
Criterion-based quality-of-care scores
Quality-of-care scores were assigned to the criterion 
in the admission, initial management and pre-
discharge phases. The method used was similar 
to that in the phase one study, whereby each time 
a criterion was ‘met’ or ‘done’ or the reviewer 
selected ‘not done’ for a valid reason option, a 
score of 1 was given. If a reviewer selected ‘not 
recorded’, the review item did not receive a score 
as this option presumes the care was not provided. 
The mean and median quality-of-care scores are 
presented in Table 39.
Box-and-whisker plots of criterion-
based total quality-of-care scores 
(Figure 34)
The box-and-whisker plots compare the median 
criterion-based quality-of-care scores and the inter-
quartile range, for each reviewer for each phase of 
care.
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Reliability between reviewers
Table 40 presents the results of the stroke criterion-
based review reliability analysis. The quality-of-care 
scores assigned to the criterion-based data was used 
to calculate ICCs for each reviewer pair.
Comparison with results from the phase 
one study
As with the holistic data, the amount of comparison 
that can be undertaken between the stroke reviewer 
reliability analysis and the main study reliability 
analysis is limited, due to the small number of 
stroke reviewers taking part.
On the whole, the reliability results for the stroke 
data are much lower than those of the phase one 
study, for which the reliability results were 0.88 
(range 0.64–0.96) for the pairs of doctor reviewers 
(Table 9). The stroke review reliability for the doctor 
pairs is much less at only 0.031, suggesting that the 
reviewers are not completing the data collection 
form in the same way. However, reliability results 
for doctors in the phase one study did vary quite 
widely between individual pairs.
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Time taken to complete reviews
Data presented in Table 41 show that each stroke 
care record review took approximately 1 hour.
The length of hospital stay for patients with stroke 
tends to be long, and the records associated with 
the care are large. From our sample, the mean 
length of stay for each patient was 33.7 days, but 
this ranged from 2 days to 314 days. Also, the 
method used was a joint holistic and criterion-
based method, with scale scores, textual data and 
review of criteria, so the length of time taken to 
perform each review is probably not unreasonable.
Quality of records
The quality of the case notes reviewed for this study 
was rated on a rating scale (1 = poor, 6 = excellent). 
Case notes received similar quality ratings from 
the clinical audit and doctor 1 reviewers, whereas 
doctor 2 tended assign a lower-quality rating than 
the other two reviewers (Table 42).
In the phase one study, the mean quality-of-case-
notes ratings for COPD and heart failure were 4.3 
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(SD 1.2) and 4.7 (SD 0.9), respectively. The stroke-
care case notes received similar ratings.
&RQFOXVLRQV
The size of this adjunct study was limited by 
resources and, subsequently, by access, thus 
reducing its generalisability. For the criterion-based 
component of the review there is some indication 
that the reviewers were able to capture a more 
complete data set than the 39 reviewers in the main 
study. This may have been due to the quality of the 
recording, and perhaps the structured nature of 
the case notes, although it is also possible that the 
reviewers were more skilled at the task than were 
the main study reviewers.
The inter-rater reliability results were poor for 
the holistic reviews, more so than the main study, 
although even the main study showed that there 
were considerable differences between reviewers 
in their inter- and intra-rater reliability. There 
may be a number of reasons for this poor level 
of agreement, including the general level of 
dificulty of providing holistic reviews of case notes 
belonging to patients who had prolonged hospital 
stays. Under such conditions, it may be that holistic 
reviewing requires a very high level of training and 
experience to be able to identify variations in care 
from the mass of available information, perhaps 
supported by electronic means of screening, such as 
might be possible by using trigger methodologies 
(Appendix 14) based on a condition-speciic set of 
review criteria.
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The initial study proposal indicated that it 
would be valuable to undertake an exploration 
of electronic trigger tool methods for assessing 
safety and quality in the two study conditions, 
acute exacerbations of COPD and heart failure, in 
contrasting trigger tools with paper-based holistic 
and criterion review.
Because this trigger tool study required research 
ethics approval it could only practically be 
undertaken in a hospital local to the study team, 
given the extent of the resource commitments 
of the main studies. It proved to be the case that 
none of the local hospitals had suficient electronic 
records systems to support even a small study. 
In the most likely setting for the research there 
were a total of seven separate paper-based record 
systems. The research commissioners therefore 
agreed that a short review of trigger tool methods 
in the context of paper-based records would be an 
appropriate alternative.
7ULJJHUWRROPHWKRGV
Health-care trigger tools were irst described by 
Classen and colleagues1 as an electronic screening 
tool for identifying markers or ‘sentinels’2 for 
possible adverse drug events (ADEs). Since this 
original prototype was developed in the context of 
a hospital with an electronic record system, it was 
possible to develop data-searching techniques that 
scanned for a drug, test or procedure that is usually 
associated with the management of an ADE. If a 
marker was found then a full review of a medical 
record could be undertaken to determine whether 
there had indeed been an avoidable event.
It should be noted here, however, that the term 
‘ADE’ includes both preventable adverse events and 
adverse drug reactions that may be unforeseeable, 
even under circumstances of the very best care. So 
the sensitivity of the original electronic trigger tool 
system for identifying safety events was limited by 
the choice of tracer – in this case an ADE.
Resar et al.2 point out that this initial trigger tool 
system had the beneit of much reducing the staff 
time that might otherwise be needed to screen 
all case notes (e.g. under circumstances when 
routine screening is identiied by an organisation 
as a priority or in a search for ADEs). Routine 
automated screening could also be carried out 
within a very short time of an event, conceivably 
within a short enough timeframe for the patient 
still to be under active management of an event.
The initial trigger tool concept applied to 
electronic records and therefore posed a potentially 
cost-effective and timely method for screening 
large numbers of case notes, of a range of patients 
and conditions. For example, Jha et al.3 reviewed 
care over 21,964 patient-days and compared the 
results of voluntary reporting of ADEs with chart 
review (398 ADEs) and computer monitoring using 
a trigger tool [2620 alerts, of which 275 (10.5%) 
were ADEs]. Little commentary was made on the 
low speciicity of the computerised alert screening 
method.
Rozich et al.4 subsequently used Classen’s1 original 
ideas to develop and test a more broadly based 
ADE trigger tool of 24 criteria, which could be 
used across a wide range of hospital types, from 
community to tertiary hospitals.
Trigger tools are essentially composed of a set of 
review criteria that are designed to identify possible 
active incidents or errors, such as the patient being 
given the wrong medication or a failure by the 
clinical team to respond to deteriorating vital signs. 
In this sense, although the evidence base on which 
they are built may be different, trigger tools are 
similar to evidence-based review criteria derived 
from clinical practice guidelines. Review criteria 
that are guideline based are more usually focused 
on positive acts than ‘incident-based’ trigger tools. 
For instance, the lack of a guideline-based review 
criterion in the case notes may indicate that an 
event has not happened – possibly linked to a 
‘failure-to-provide’ event. For example, the failure 
$SSHQGL[
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to record that a measure of glucose level has been 
taken in a person with diabetes might indicate a 
more general failure to actively manage the case.
Initially, trigger tools were used either in near 
‘real time’ or, retrospectively, from paper-based or 
electronic records, to identify possible preventable 
events in medication safety. Trigger technology 
was subsequently broadened to identify possible 
harm in services such as paediatric intensive 
care,5 where situation-speciic trigger criteria have 
been developed to screen for some of the more 
frequently occurring, preventable, safety events. 
In the initial validation study of this tool, the most 
commonly identiied adverse events were health-
care-associated infections, catheter iniltrates and 
unplanned extubations requiring reintubation. 
Trigger tools for adult intensive care have included 
such criteria as abrupt falls in haemoglobin level – 
indicative of severe bleeding – or the occurrence of 
a case of pneumonia in a person who is already a 
patient in a hospital.6
Recent developments have taken a different 
approach in looking globally for adverse events 
across whole hospital inpatient systems,7 and 
providing a measure for comparing one hospital’s 
results with another, using denominators such as:
• adverse events per 1000 patient-days, or
• adverse events per 100 admissions, or
• percentage of admissions with an adverse 
event.
More controversially, the Institute of Healthcare 
Improvement (IHI)8 has developed an outpatient 
care trigger tool that ‘bands together multiple 
episodes of care across a continuum’,8 using 
triggers data from malpractice claims to categorise 
outpatient-care-related adverse events. The tool 
comprises 11 criteria ‘to provide “clues” to the 
possibility of adverse events in a patient record’.8
6WUHQJWKVDQGZHDNQHVVHVRIWULJJHUWRRO
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Although the value of using the electronic 
screening trigger programs has been recognised, 
it is also apparent that many hospital record 
systems are still paper based, so that more recent 
versions of trigger tools have been directed towards 
supporting the screening of case notes by trained 
reviewers, using what is effectively a criterion-
based, explicit approach. Just like review criteria, 
trigger tools bring structure to a review, being 
used as a framework for screening case notes or 
electronic records and identifying pointers to 
potential adverse events, which are then explored 
through full, holistic case note review.
Although these more broadly based service reviews 
are now being more widely promoted by the IHI 
and through projects in the UK NHS,8 rather less 
is currently being said about the limitations of the 
method. These limitations can be seen as:
1. development effort required for the criteria for 
the trigger tool
2. requirement for case note review when trigger 
criteria are found
3. validity and interpretation of the results.
Development resource
Extensive effort is required to develop a set of 
review criteria that have some evidence base, face 
validity and reproducibility. Although Resar and 
colleagues2 do not indicate how much effort was 
required to develop the four trigger programs they 
outline in their 2003 review article, they indicate 
in another article that many person-hours were 
required to develop the IHI adverse drug event 
tool.7
To create trigger tools for (types of) adverse events, 
it would be necessary irst to create an initial list 
of possible adverse events for a clinical condition 
or care setting – this has been the approach in the 
IHI global adverse events tool.7 Once an initial list 
of trigger criteria is developed then validation and 
reproducibility testing adds a further burden. For 
instance, development of the IHI medication tool4 
was undertaken in 86 hospitals and was based on 
a review of 2837 records. This is a highly resource-
intensive process and it is unlikely that this level 
of funding will available often, particularly in the 
UK, so that trigger tools are likely to be limited in 
number, and, for the foreseeable future, essentially 
of North American origin.
Use of case note review
During a screening review using trigger tools, a 
positive inding of any one criterion requires that 
a full case note review must be undertaken. Resar 
and colleagues2 point out that ‘the reviewer must 
review the use of the trigger in the context of the 
care documented’. For example, in a medication 
review an event that appears to be an ADE may 
be an adverse drug reaction (unpredictable and 
probably not preventable) rather than an adverse 
event.
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One of the key limitations of trigger technology is 
that any adverse events not identiied by a trigger 
would be missed9 unless a general screen was 
carried out, which defeats the eficiency purpose. 
Moreover, it could be argued that if it takes around 
15–20 minutes4 to manually scan to identify one 
in a set of adverse review criteria, this is about the 
same length of time that an experienced reviewer 
might take to undertake a structured implicit 
review. The IHI trigger tool study4 used full 
retrospective case note review with 23 (together 
with one open) review criteria. Instead of being a 
screening tool, therefore, the trigger criteria could 
be seen part of a mixed explicit/implicit case note 
review methodology.
Validity and interpretation of the 
results
When trigger tools are developed using rigorous 
methods and with extensive validation, there is 
undoubtedly a role for such review methods when 
they are used to review sets of case notes within an 
institution, and, in combination with full implicit 
review, they can also be used to explore safety and 
quality between institutions. However, Brown and 
colleagues10 point out a number of methodological 
limitations when trigger results alone are used as 
screening methods. Under such circumstances, the 
arguments comprise concerns over both sensitivity 
and speciicity.
The authors identify the problem of a lack of a 
‘gold standard’ for identifying the actual level 
of events occurring (even observation is not an 
accurate measure), so that the sensitivity of a 
speciic trigger tool – for example for measuring 
the rate of ADEs in a particular population – may 
be higher than reported but is not as high as some 
other (possibly more expensive) methods, such as 
full holistic review. Trigger tools can, of course, be 
used denominator free or used with a denominator 
such as 100 bed-days, just the same as in criterion-
based clinical audit.
If the speciicity of the criteria in a trigger tool is 
high then only a narrow range of events may be 
identiied. Conversely, Brown and colleagues10 
point out that if speciicity is low then there will 
be many false-positives and resource ineficient 
review. Use of tools with low levels of speciicity 
might yield biased data in comparisons between 
organisations.
,VWKHUHDUROHIRUWULJJHUWRROVLQFDVH
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The application of trigger tools to care for chronic 
conditions is certainly possible, in somewhat similar 
manner to the production of evidence-based 
review criteria. In the evaluation of safety, trigger 
tools have some advantage in that they can be 
developed to directly identify possible poor care, 
unlike the more usual review criteria that usually 
indicate possible gaps in care. However, the extent 
of the development work required to identify the 
range of indicators needed to trace possible laws 
in care might be even greater than that needed 
for evidence-based review criteria to evaluate the 
process of care delivery.
It is likely, therefore, that only limited trigger tool 
sets of criteria will be available in the foreseeable 
future and that these will be more likely to be 
applied to speciic instances, such as medication 
events, or to complex and event prone settings, 
such as intensive care units.
Nevertheless, where trigger tool criteria do exist 
it may be worth exploring their use as electronic 
medical records become commonplace in hospitals. 
While methodological limitations will remain, and 
care will be required in interpreting data from 
trigger tools that are used to provide ‘comparable’ 
data, research should be undertaken on the utility 
of a combined method of trigger tool screening 
with structured holistic review of identiied records.
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